<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Asthma - Disorder Mechanisms</title>
    <style>
        :root {
            --primary: #0f766e;
            --primary-light: #14b8a6;
            --primary-dark: #0d5c56;
            --secondary: #6366f1;
            --bg: #f0fdfa;
            --card-bg: #ffffff;
            --text: #134e4a;
            --text-muted: #5f7a78;
            --border: #ccfbf1;
            --accent-orange: #f59e0b;
            --accent-rose: #f43f5e;
            --accent-violet: #8b5cf6;
            --accent-sky: #0ea5e9;
        }

        * { box-sizing: border-box; margin: 0; padding: 0; }

        body {
            font-family: 'Segoe UI', system-ui, -apple-system, sans-serif;
            background: var(--bg);
            color: var(--text);
            line-height: 1.7;
        }

        .container {
            max-width: 1100px;
            margin: 0 auto;
            padding: 24px;
        }

        /* Header */
        .page-header {
            background: linear-gradient(135deg, var(--primary) 0%, var(--primary-dark) 100%);
            color: white;
            padding: 40px 32px;
            border-radius: 16px;
            margin-bottom: 24px;
            position: relative;
            overflow: hidden;
        }

        .page-header::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -20%;
            width: 400px;
            height: 400px;
            background: rgba(255,255,255,0.05);
            border-radius: 50%;
        }

        .page-header h1 {
            font-size: 2.2rem;
            font-weight: 700;
            margin-bottom: 12px;
            position: relative;
        }

        .header-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 12px;
            align-items: center;
            position: relative;
        }

        .badge {
            display: inline-flex;
            align-items: center;
            padding: 6px 14px;
            border-radius: 20px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .badge-category {
            background: rgba(255,255,255,0.2);
            color: white;
        }

        .badge-mondo {
            background: var(--accent-sky);
            color: white;
        }

        .badge-mondo a {
            color: inherit;
            text-decoration: none;
        }

        .badge-mondo a:hover {
            text-decoration: underline;
        }

        /* Navigation */
        .breadcrumb {
            margin-bottom: 16px;
            font-size: 0.9rem;
        }

        .breadcrumb a {
            color: var(--primary);
            text-decoration: none;
        }

        .breadcrumb a:hover {
            text-decoration: underline;
        }

        .breadcrumb span {
            color: var(--text-muted);
        }

        /* Cards */
        .card {
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            padding: 24px;
            margin-bottom: 20px;
            box-shadow: 0 1px 3px rgba(0,0,0,0.04);
        }

        .card-header {
            display: flex;
            align-items: center;
            gap: 12px;
            margin-bottom: 16px;
            padding-bottom: 12px;
            border-bottom: 2px solid var(--border);
        }

        .card-icon {
            width: 36px;
            height: 36px;
            border-radius: 8px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 1.2rem;
        }

        .card-title {
            font-size: 1.1rem;
            font-weight: 600;
            color: var(--text);
        }

        .card-count {
            margin-left: auto;
            background: var(--bg);
            padding: 4px 12px;
            border-radius: 12px;
            font-size: 0.8rem;
            color: var(--text-muted);
        }

        /* Sections */
        .section-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(320px, 1fr));
            gap: 20px;
        }

        /* Tags */
        .tag-list {
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
        }

        .tag {
            padding: 6px 12px;
            border-radius: 6px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .tag-cell {
            background: #fce7f3;
            color: #9d174d;
        }

        .tag-gene {
            background: #dbeafe;
            color: #1e40af;
        }

        .tag-treatment {
            background: #ede9fe;
            color: #5b21b6;
        }

        .tag-env {
            background: #ccfbf1;
            color: #0f766e;
        }

        .tag-bio {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-parent {
            background: #e0e7ff;
            color: #3730a3;
        }

        /* Evidence styling */
        .evidence-toggle {
            cursor: pointer;
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 10px;
            user-select: none;
        }

        .evidence-toggle:hover {
            color: var(--primary);
        }

        .evidence-list {
            margin-top: 10px;
            padding-left: 0;
        }

        .evidence-item {
            padding: 12px 14px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .evidence-header {
            display: flex;
            align-items: center;
            flex-wrap: wrap;
            gap: 8px;
        }

        .evidence-ref {
            font-weight: 600;
            color: var(--secondary);
        }

        .evidence-ref a {
            color: inherit;
            text-decoration: none;
        }

        .evidence-ref a:hover {
            text-decoration: underline;
        }

        .evidence-support {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
        }

        .support-SUPPORT { background: #dcfce7; color: #166534; }
        .support-PARTIAL { background: #fef3c7; color: #92400e; }
        .support-REFUTE { background: #fee2e2; color: #991b1b; }
        .support-NO_EVIDENCE { background: #f1f5f9; color: #64748b; }
        .support-WRONG_STATEMENT { background: #fecaca; color: #7f1d1d; }

        .evidence-snippet {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 8px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        .evidence-explanation {
            font-size: 0.85rem;
            color: var(--text);
            margin-top: 6px;
            line-height: 1.5;
        }

        .evidence-more {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 6px;
            font-style: italic;
        }

        /* Item containers with evidence */
        .item-box {
            padding: 16px;
            border-radius: 10px;
            margin-bottom: 12px;
        }

        .item-name {
            font-weight: 600;
            margin-bottom: 6px;
        }

        .item-desc {
            font-size: 0.9rem;
            line-height: 1.6;
            margin-bottom: 8px;
        }

        .item-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            margin-top: 8px;
        }

        /* Pathophysiology */
        .pathophys-box {
            background: linear-gradient(135deg, #fef3c7 0%, #fef9c3 100%);
            border-left: 4px solid var(--accent-orange);
        }
        .pathophys-box .item-name { color: #92400e; }
        .pathophys-box .item-desc { color: #78350f; }

        /* Phenotypes */
        .phenotype-box {
            background: #f0fdf4;
            border-left: 4px solid #22c55e;
        }
        .phenotype-box .item-name { color: #166534; }
        .phenotype-box .item-desc { color: #15803d; }

        .phenotype-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #dcfce7;
            color: #15803d;
        }

        .phenotype-category {
            font-size: 0.75rem;
            color: #4ade80;
        }

        .phenotype-id a {
            font-size: 0.8rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .phenotype-id a:hover {
            text-decoration: underline;
        }

        /* Genetic */
        .genetic-box {
            background: #eff6ff;
            border-left: 4px solid #3b82f6;
        }
        .genetic-box .item-name { color: #1e40af; }
        .genetic-box .item-desc { color: #2563eb; }

        /* Treatment */
        .treatment-box {
            background: #faf5ff;
            border-left: 4px solid #8b5cf6;
        }
        .treatment-box .item-name { color: #5b21b6; }
        .treatment-box .item-desc { color: #7c3aed; }

        /* Environmental */
        .environmental-box {
            background: #f0fdfa;
            border-left: 4px solid #14b8a6;
        }
        .environmental-box .item-name { color: #0f766e; }
        .environmental-box .item-desc { color: #0d9488; }

        /* Biochemical */
        .biochemical-box {
            background: #fffbeb;
            border-left: 4px solid #f59e0b;
        }
        .biochemical-box .item-name { color: #92400e; }
        .biochemical-box .item-desc { color: #b45309; }

        /* Differential Diagnoses */
        .differential-box {
            background: #fef2f2;
            border-left: 4px solid #dc2626;
        }
        .differential-box .item-name { color: #7f1d1d; }
        .differential-box .item-desc { color: #b91c1c; }

        .differential-similarities {
            background: #fee2e2;
            border-left: 2px solid #dc2626;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-distinctions {
            background: #dcfce7;
            border-left: 2px solid #16a34a;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-similarities strong,
        .differential-distinctions strong {
            display: block;
            margin-bottom: 6px;
            font-size: 0.85rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        .differential-similarities ul,
        .differential-distinctions ul {
            margin-left: 16px;
            line-height: 1.6;
        }

        .differential-similarities li,
        .differential-distinctions li {
            margin: 4px 0;
            font-size: 0.9rem;
        }

        /* Datasets */
        .dataset-box {
            background: #f0f9ff;
            border-left: 4px solid #0284c7;
        }
        .dataset-box .item-name { color: #0c4a6e; }
        .dataset-box .item-desc { color: #0369a1; }

        .tag-dataset {
            background: #e0f2fe;
            color: #0369a1;
        }

        .tag-organism {
            background: #fae8ff;
            color: #a21caf;
        }

        .tag-datatype {
            background: #dbeafe;
            color: #1d4ed8;
        }

        .dataset-accession a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .dataset-accession a:hover {
            text-decoration: underline;
        }

        /* Subtypes */
        .subtype-box {
            background: #eef2ff;
            border-left: 4px solid var(--secondary);
        }
        .subtype-box .item-name { color: #3730a3; }
        .subtype-box .item-desc { color: #4f46e5; }

        /* Stats bar */
        .stats-bar {
            display: flex;
            gap: 24px;
            padding: 20px 24px;
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            margin-bottom: 24px;
            flex-wrap: wrap;
        }

        .stat-item {
            text-align: center;
        }

        .stat-value {
            font-size: 1.5rem;
            font-weight: 700;
            color: var(--primary);
        }

        .stat-label {
            font-size: 0.8rem;
            color: var(--text-muted);
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        /* YAML preview */
        .yaml-preview {
            background: #1e293b;
            color: #e2e8f0;
            padding: 20px;
            border-radius: 8px;
            overflow-x: auto;
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            line-height: 1.5;
            max-height: 400px;
            overflow-y: auto;
        }

        .yaml-content {
            display: none;
        }

        .yaml-content.show {
            display: block;
        }

        /* Footer */
        .page-footer {
            margin-top: 40px;
            padding-top: 20px;
            border-top: 1px solid var(--border);
            text-align: center;
            color: var(--text-muted);
            font-size: 0.85rem;
        }

        .page-footer a {
            color: var(--primary);
            text-decoration: none;
        }

        .page-footer a:hover {
            text-decoration: underline;
        }

        /* Responsive */
        @media (max-width: 768px) {
            .page-header h1 { font-size: 1.6rem; }
            .stats-bar { gap: 16px; }
            .section-grid { grid-template-columns: 1fr; }
        }
        /* Mermaid graph */
        .mermaid-container {
            text-align: center;
            margin: 20px 0;
            padding: 20px;
            background: white;
            border-radius: 8px;
            border: 1px solid var(--border);
            overflow-x: auto;
        }

        .mermaid svg {
            max-width: 100%;
            height: auto;
        }

        .graph-warning {
            background: #fef3c7;
            border: 1px solid #f59e0b;
            border-radius: 8px;
            padding: 12px 16px;
            margin-bottom: 16px;
            font-size: 0.85rem;
            color: #92400e;
        }

        .graph-warning strong {
            display: block;
            margin-bottom: 4px;
        }

        .graph-warning ul {
            margin: 8px 0 0 20px;
            padding: 0;
        }

        .graph-warning li {
            margin: 4px 0;
        }
    </style>
    <script src="https://cdn.jsdelivr.net/npm/mermaid@10/dist/mermaid.min.js"></script>
    <script>
        mermaid.initialize({
            startOnLoad: true,
            theme: 'default',
            flowchart: {
                htmlLabels: true,
                curve: 'basis'
            }
        });
    </script>
</head>
<body>
    

    
    

    

    <div class="container">
        <nav class="breadcrumb">
            <a href="../../app/index.html">Browse All</a>
            <span> / </span>
            <span>Asthma</span>
        </nav>

        <header class="page-header">
            <h1>Asthma</h1>
            <div class="header-meta">
                
                <span class="badge badge-category">Complex</span>
                
                
                <span class="badge badge-mondo">
                    <a href="https://monarchinitiative.org/disease/MONDO:0004979" target="_blank">
                        MONDO:0004979
                    </a>
                </span>
                
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Respiratory Disease</span>
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Chronic Inflammatory Disease</span>
                
            </div>
        </header>

        <!-- Stats bar -->
        <div class="stats-bar">
            <div class="stat-item">
                <div class="stat-value">4</div>
                <div class="stat-label">Mechanisms</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">12</div>
                <div class="stat-label">Phenotypes</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">6</div>
                <div class="stat-label">Genes</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">5</div>
                <div class="stat-label">Treatments</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">5</div>
                <div class="stat-label">Subtypes</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Differentials</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">6</div>
                <div class="stat-label">Datasets</div>
            </div>
        </div>

        <!-- Subtypes -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #eef2ff; color: #4f46e5;">◆</div>
                <h2 class="card-title">Subtypes</h2>
                <span class="card-count">5</span>
            </div>
            
            <div class="item-box subtype-box">
                <div class="item-name">Allergic Asthma</div>
                
                <div class="item-desc">Triggered by allergens such as pollen, pet dander, or dust mites.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/32037107" target="_blank">PMID:32037107</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Allergic asthma is defined as asthma associated with sensitization to aeroallergens, which leads to asthma symptoms and airway inflammation."</div>
                
                
                <div class="evidence-explanation">The literature explicitly states that allergic asthma is triggered by allergens.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/24925403" target="_blank">PMID:24925403</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Allergic diseases triggered by mite allergens include allergic rhinoconjunctivitis, asthma, atopic dermatitis and other skin diseases."</div>
                
                
                <div class="evidence-explanation">This literature confirms asthma can be triggered by mite allergens, consistent with the definition of allergic asthma.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/32589303" target="_blank">PMID:32589303</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Respiratory health can be particularly affected by climate change, which contributes to the development of allergic respiratory diseases and asthma."</div>
                
                
                <div class="evidence-explanation">The document indicates that climate change contributes to the development of asthma, supporting the statement.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box subtype-box">
                <div class="item-name">Non-Allergic Asthma</div>
                
                <div class="item-desc">Triggered by factors such as stress, exercise, cold air, or respiratory infections.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/11678516" target="_blank">PMID:11678516</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                </div>
                
                <div class="evidence-snippet">"Asthmatic attack in exercise-induced asthma is brought about by hyperventilation (not necessarily to exercise), cold air, and low humidity of the air breathed."</div>
                
                
                <div class="evidence-explanation">The reference discusses asthma subtypes triggered by exercise, cold air, and respiratory conditions, but does not explicitly mention stress or classify it specifically as &#39;Non-Allergic Asthma&#39;.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/25439356" target="_blank">PMID:25439356</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                </div>
                
                <div class="evidence-snippet">"First, asthma phenotypes that are associated with environmental exposures (occupational agents, cigarette smoke, air pollution, cold dry air)..."</div>
                
                
                <div class="evidence-explanation">The reference mentions environmental exposures like cold dry air and non-allergic triggers, but does not explicitly identify stress or exercise specifically in relation to &#39;Non-Allergic Asthma&#39;.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/20176257" target="_blank">PMID:20176257</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Indoor and outdoor air pollutants trigger airway inflammation and increase the severity of asthma."</div>
                
                
                <div class="evidence-explanation">The reference corroborates that environmental pollutants are triggers for asthma exacerbations.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box subtype-box">
                <div class="item-name">Adult-Onset Asthma</div>
                
                <div class="item-desc">Develops later in adult life and often triggered by environmental factors.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/36833767" target="_blank">PMID:36833767</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Only a few previous studies have investigated the subtypes of adult-onset asthma. No previous study has assessed whether these subtypes are different between men and women, or whether these subtypes have different risk factors."</div>
                
                
                <div class="evidence-explanation">The reference discusses subtypes of adult-onset asthma and emphasizes the importance of different risk factors, which supports that adult-onset asthma could have environmental triggers.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/30240884" target="_blank">PMID:30240884</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Adult-onset asthma is an important asthma phenotype and, in contrast to childhood asthma, is often associated with specific triggers of onset."</div>
                
                
                <div class="evidence-explanation">This study indicates that adult-onset asthma is often associated with specific triggers of onset, which aligns with the statement that it is often triggered by environmental factors.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/20176257" target="_blank">PMID:20176257</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Exposure to unusual substances at work causes occupational asthma, accounting for about 5% of asthma in adults. Indoor and outdoor air pollutants trigger airway inflammation and increase the severity of asthma."</div>
                
                
                <div class="evidence-explanation">The literature specifies that environmental factors such as pollutants can trigger adult asthma, further supporting the statement about environmental triggers.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box subtype-box">
                <div class="item-name">Asthma-COPD Overlap</div>
                
                <div class="item-desc">Features of both chronic obstructive pulmonary disease and asthma.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/26398072" target="_blank">PMID:26398072</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Although in textbooks asthma and chronic obstructive pulmonary disease (COPD) are viewed as distinct disorders, there is increasing awareness that many patients have features of both. This article reviews the asthma-COPD overlap syndrome."</div>
                
                
                <div class="evidence-explanation">The article explicitly refers to the Asthma-COPD Overlap Syndrome, which indicates the presence of subtypes sharing features of both asthma and COPD.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/24507842" target="_blank">PMID:24507842</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Asthma in childhood and COPD in smokers have their own phenotypic expression with underlying pathophysiological mechanisms that differ importantly. In older adults, asthma and COPD are more difficult to differentiate and there exists a bronchodilator response in most but not all patients with..."</div>
                
                
                <div class="evidence-explanation">The article acknowledges overlapping phenotypes between asthma and COPD, supporting the existence of a subtype with features of both diseases.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/29713158" target="_blank">PMID:29713158</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Asthma and COPD are heterogeneous diseases. Patients with both disease features (asthma-COPD overlap ...) are common."</div>
                
                
                <div class="evidence-explanation">This article clearly supports that there is an overlap between asthma and COPD, validating the statement about the Asthma-COPD Overlap subtype with shared features.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box subtype-box">
                <div class="item-name">Exercise-Induced Asthma</div>
                
                <div class="item-desc">Often triggered by physical exertion.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/22794682" target="_blank">PMID:22794682</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"patients with asthma may be classified as allergic (IgE mediated), nonallergic (often triggered by viral upper respiratory tract infections or no apparent cause), occupational, aspirin-exacerbated respiratory disease, potentially (near) fatal, exercise induced, and cough variant asthma."</div>
                
                
                <div class="evidence-explanation">This reference explicitly lists exercise-induced asthma as a subtype of asthma, supporting the statement.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/5002114" target="_blank">PMID:5002114</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"This study indicates that swimming should be recommended in preference to running or cycling as an exercise programme for adults and children with asthma."</div>
                
                
                <div class="evidence-explanation">This study highlights exercise-induced asthma and provides insights into managing physical activities for those with this subtype.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/22157157" target="_blank">PMID:22157157</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Exercise-induced bronchoconstriction (EIB) refers to acute airflow obstruction that is triggered by a period of physical exertion."</div>
                
                
                <div class="evidence-explanation">This study details the pathology of exercise-induced bronchoconstriction, commonly referred to as exercise-induced asthma, supporting the statement.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Pathophysiology -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">⚙</div>
                <h2 class="card-title">Pathophysiology</h2>
                <span class="card-count">4</span>
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Airway Inflammation</div>
                
                <div class="item-desc">Chronic inflammation leads to airway hyperresponsiveness and recurrent episodes of wheezing, breathlessness, chest tightness, and coughing.</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        Mast Cell
                        
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000097" target="_blank" style="color: inherit; margin-left: 4px;">↗</a>
                        
                    </span>
                    
                    <span class="tag tag-cell">
                        Eosinophil
                        
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000771" target="_blank" style="color: inherit; margin-left: 4px;">↗</a>
                        
                    </span>
                    
                    <span class="tag tag-cell">
                        T-Lymphocyte
                        
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000084" target="_blank" style="color: inherit; margin-left: 4px;">↗</a>
                        
                    </span>
                    
                    <span class="tag tag-cell">
                        Bronchial Epithelial Cell
                        
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0002328" target="_blank" style="color: inherit; margin-left: 4px;">↗</a>
                        
                    </span>
                    
                    <span class="tag tag-cell">
                        Basophil
                        
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000767" target="_blank" style="color: inherit; margin-left: 4px;">↗</a>
                        
                    </span>
                    
                    <span class="tag tag-cell">
                        Neutrophil
                        
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000775" target="_blank" style="color: inherit; margin-left: 4px;">↗</a>
                        
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (8 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/18503727" target="_blank">PMID:18503727</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"The pathogenesis of allergic airway inflammation is complex, involving multiple cell types such as T helper 2 cells, regulatory T cells, eosinophils, dendritic cells, mast cells, and parenchymal cells of the lung."</div>
                
                
                <div class="evidence-explanation">This reference indicates the involvement of multiple cell types, including mast cells, eosinophils, and T lymphocytes in allergic airway inflammation, which supports the statement.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/8324396" target="_blank">PMID:8324396</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"The numbers of eosinophils and neutrophils are increased 4 h after challenge with allergen in the broncho-alveolar lavage fluid (BAL) of asthmatics who show an LPR."</div>
                
                
                <div class="evidence-explanation">This reference mentions eosinophils and neutrophils as part of the chronic inflammatory response in asthma, supporting the statement.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/9753516" target="_blank">PMID:9753516</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Accumulation of basophils and mast cells in airway tissues during allergic and allergic-type inflammatory responses, including asthma, is one of the hallmarks of these disease processes."</div>
                
                
                <div class="evidence-explanation">This reference highlights the involvement of basophils and mast cells in airway inflammation in asthma, supporting the statement.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 5 more references</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Bronchoconstriction</div>
                
                <div class="item-desc">During an asthma attack, smooth muscles around the airways tighten and narrow the airway.</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        Smooth Muscle Cells
                        
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000192" target="_blank" style="color: inherit; margin-left: 4px;">↗</a>
                        
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (5 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/24914235" target="_blank">PMID:24914235</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"The other main cause of airway obstruction is contraction of airway smooth muscle."</div>
                
                
                <div class="evidence-explanation">The reference points out that contraction of airway smooth muscle is a main cause of airway obstruction, thus supporting the statement.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/22011234" target="_blank">PMID:22011234</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Breathing difficulties are caused by excessive narrowing of the pulmonary airways, which is instigated by shortening of the airway smooth muscle (ASM)."</div>
                
                
                <div class="evidence-explanation">This reference explains that the narrowing of the airways, caused by the contraction of airway smooth muscle, leads to breathing difficulties, thus supporting the statement.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/27603525" target="_blank">PMID:27603525</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"In acute and chronic allergen driven animal models of asthma, statins reduce airway hyper-responsiveness, inflammation and remodeling."</div>
                
                
                <div class="evidence-explanation">The use of statins to reduce airway hyper-responsiveness implies the involvement of smooth muscle cells, supporting the statement.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 2 more references</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Mucus Overproduction</div>
                
                <div class="item-desc">Inflammatory cells infiltrate the airways, increasing mucus production, which can block airways and further impair breathing.</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        Goblet Cell
                        
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000160" target="_blank" style="color: inherit; margin-left: 4px;">↗</a>
                        
                    </span>
                    
                    <span class="tag tag-cell">
                        Bronchial Epithelial Cell
                        
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0002328" target="_blank" style="color: inherit; margin-left: 4px;">↗</a>
                        
                    </span>
                    
                    <span class="tag tag-cell">
                        Mucosal Epithelial Cell
                        
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0002202" target="_blank" style="color: inherit; margin-left: 4px;">↗</a>
                        
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (5 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/19689269" target="_blank">PMID:19689269</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                </div>
                
                <div class="evidence-snippet">"Goblet cells are major mucus-producing cells, and goblet cell hyperplasia (GCH) is one feature of airway remodeling, defined as structural changes occurring in the airway."</div>
                
                
                <div class="evidence-explanation">The reference confirms Goblet cell involvement in asthma and mucus production but does not mention Mucosal Epithelial Cell specifically.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/24914235" target="_blank">PMID:24914235</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                </div>
                
                <div class="evidence-snippet">"Airway epithelial cells, which are the first line of defense against inhaled pathogens and particles, initiate airway inflammation and produce mucus, an important contributor to airway obstruction."</div>
                
                
                <div class="evidence-explanation">The reference supports that Bronchial Epithelial Cells play a role in mucus production but does not discuss Mucosal Epithelial Cells specifically.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/37520564" target="_blank">PMID:37520564</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                </div>
                
                <div class="evidence-snippet">"Basal cells... goblet cell hyperplasia and increased epithelial mesenchymal transition, which contribute to impaired mucociliary clearance and airway remodelling."</div>
                
                
                <div class="evidence-explanation">The reference confirms Goblet cell hyperplasia and the contribution of epithelial cells in asthma but does not detail Mucosal Epithelial Cells.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 2 more references</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Airway Remodeling</div>
                
                <div class="item-desc">Long-standing inflammation can lead to structural changes in the airway, permanently affecting lung function.</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        Fibroblast
                        
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000057" target="_blank" style="color: inherit; margin-left: 4px;">↗</a>
                        
                    </span>
                    
                    <span class="tag tag-cell">
                        Smooth Muscle Cell
                        
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000192" target="_blank" style="color: inherit; margin-left: 4px;">↗</a>
                        
                    </span>
                    
                    <span class="tag tag-cell">
                        Bronchial Epithelial Cell
                        
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0002328" target="_blank" style="color: inherit; margin-left: 4px;">↗</a>
                        
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (5 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/20500603" target="_blank">PMID:20500603</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"In asthma, it includes alterations of the epithelial cell layer with goblet cell hyperplasia, thickening of basement membranes, peri-bronchial and peri-bronchoalveolar fibrosis."</div>
                
                
                <div class="evidence-explanation">The reference acknowledges that airway remodeling in asthma involves changes to the epithelial cell layer, fibroblasts, and smooth muscle cells.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/10907591" target="_blank">PMID:10907591</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"In the long-term, asthma may become moderately to fully irreversible. Severe, irreversible airflow obstruction may develop despite apparently appropriate therapy."</div>
                
                
                <div class="evidence-explanation">The reference supports the idea that long-standing inflammation can result in irreversible structural changes affecting lung function.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/15896192" target="_blank">PMID:15896192</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Structural changes reported in the airways of asthmatics include epithelial fragility, goblet cell hyperplasia, enlarged submucosal mucus glands, angiogenesis, increased matrix deposition in the airway wall, increased airway smooth muscle mass, wall thickening and abnormalities in elastin."</div>
                
                
                <div class="evidence-explanation">The reference details structural changes involving various cell types, including epithelial cells, smooth muscle cells, and other airway structures resulting from long-term inflammation in asthma.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 2 more references</div>
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Causal Graph -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #e0e7ff; color: #4f46e5;">⬡</div>
                <h2 class="card-title">Causal Graph</h2>
            </div>
            
            <div class="mermaid-container">
                <pre class="mermaid">graph TD
    Wheezing[&#34;Wheezing&#34;]
    Airway_Inflammation[&#34;Airway Inflammation&#34;]
    Respiratory_Distress[&#34;Respiratory Distress&#34;]
    Bronchoconstriction[&#34;Bronchoconstriction&#34;]
    Reduced_Exercise_Tolerance[&#34;Reduced Exercise Tolerance&#34;]

    Airway_Inflammation --&gt; Bronchoconstriction
    Wheezing --&gt; Respiratory_Distress
    Wheezing --&gt; Reduced_Exercise_Tolerance

    style Wheezing fill:#fef3c7
    style Airway_Inflammation fill:#dbeafe
    style Respiratory_Distress fill:#fef3c7
    style Bronchoconstriction fill:#dbeafe
    style Reduced_Exercise_Tolerance fill:#fef3c7</pre>
            </div>
        </div>
        

        <!-- Phenotypes -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #dcfce7; color: #16a34a;">●</div>
                <h2 class="card-title">Phenotypes</h2>
                <span class="card-count">12</span>
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Wheezing
                    
                    <span class="phenotype-freq">FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Respiratory</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="https://hpo.jax.org/browse/term/HP:0030828" target="_blank">
                            HP:0030828
                        </a>
                    </span>
                    
                </div>
                
                
                <div class="item-meta">
                    <strong style="font-size: 0.8rem; color: #166534;">Sequelae:</strong>
                    
                    <span class="tag" style="background: #bbf7d0; color: #166534;">Respiratory Distress</span>
                    
                    <span class="tag" style="background: #bbf7d0; color: #166534;">Reduced Exercise Tolerance</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (6 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/20545704" target="_blank">PMID:20545704</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"It has been suggested that there are several distinct phenotypes of childhood asthma or childhood wheezing. Here, we review the research relating to these phenotypes, with a focus on the methods used to define and validate them."</div>
                
                
                <div class="evidence-explanation">The reference supports the existence and classification of asthma phenotypes, including wheezing as a common characteristic.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/8620967" target="_blank">PMID:8620967</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Wheezes are usual clinical signs in patients with obstructive airway diseases and particularly during acute episodes of asthma."</div>
                
                
                <div class="evidence-explanation">The reference describes wheezing as a common symptom associated with asthma, supporting the statement&#39;s claim that wheezing is a common phenotype and respiratory diagnostic of asthma.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/1788358" target="_blank">PMID:1788358</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Exercise-induced asthma is a common but frequently undiagnosed problem. The patient may not wheeze, but rather have shortness of breath, chest tightening, and coughing."</div>
                
                
                <div class="evidence-explanation">This reference mentions exercise-induced asthma and details its symptoms, including wheezing, though noting that wheezing may not always be present.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 3 more references</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Coughing
                    
                    <span class="phenotype-freq">FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Respiratory</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="https://hpo.jax.org/browse/term/HP:0012735" target="_blank">
                            HP:0012735
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/36096782" target="_blank">PMID:36096782</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Asthma is a heterogeneous disease with variable symptoms, which presents with cough either as the sole or predominant symptom with or without wheezing."</div>
                
                
                <div class="evidence-explanation">The reference states that cough is a common phenotype in asthma, aligning with the statement&#39;s claim that coughing is a common respiratory phenotype in asthma.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/31662445" target="_blank">PMID:31662445</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Asthma severity was dependent on variety of symptoms, consisting mostly of wheezing, breathlessness, chest tightness, and cough."</div>
                
                
                <div class="evidence-explanation">The reference indicates that coughing is one of the primary symptoms associated with asthma, supporting the claim that it is a common respiratory phenotype.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/36543577" target="_blank">PMID:36543577</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Chronic cough is associated with poor quality of life and can negatively affect quality of life. Diseases causing chronic cough are most commonly asthma, eosinophilic bronchitis, gastroesophageal reflux, post-nasal drip syndrome, rhinosinusitis, chronic obstructive pulmonary disease, pulmonary..."</div>
                
                
                <div class="evidence-explanation">The reference supports the association of chronic cough with asthma, aligning with the statement that coughing is a common phenotype in asthma.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Breathlessness
                    
                    <span class="phenotype-freq">FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Respiratory</span>
                    
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/34610625" target="_blank">PMID:34610625</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Respiratory diseases were the main underlying condition (40-57%), of which asthma was the most common (approx. 25%), and chronic obstructive pulmonary disease was particularly strongly associated with breathlessness."</div>
                
                
                <div class="evidence-explanation">The reference indicates that respiratory diseases, including asthma, are a common underlying condition for breathlessness. This supports the categorization of breathlessness as a common respiratory phenotype of asthma.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Chest Tightness
                    
                    <span class="phenotype-freq">FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Respiratory</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="https://hpo.jax.org/browse/term/HP:0031352" target="_blank">
                            HP:0031352
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/31662445" target="_blank">PMID:31662445</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"CONCLUSIONS: Asthma severity was dependent on variety of symptoms, consisting mostly of wheezing, breathlessness, chest tightness, and cough."</div>
                
                
                <div class="evidence-explanation">The literature indicates that chest tightness is among the most common symptoms of asthma, supporting the statement that chest tightness is a frequent phenotype of respiratory symptoms in asthma patients.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/36292755" target="_blank">PMID:36292755</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Asthma is a chronic disease of the airways characterized by inflammation, tightened muscles, and thickened airway walls leading to symptoms such as shortness of breath, chest tightness, and cough in patients."</div>
                
                
                <div class="evidence-explanation">This article confirms that chest tightness is a common symptom of asthma, supporting the statement.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/3595047" target="_blank">PMID:3595047</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"IMPLICATIONS: exercise-induced asthma should be considered in pediatric patients with symptoms of chest pain or dyspnea on exertion."</div>
                
                
                <div class="evidence-explanation">Exercise-induced asthma includes symptoms like chest pain, which is related to chest tightness, supporting the statement.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Rapid Breathing
                    
                    <span class="phenotype-freq">FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Respiratory</span>
                    
                    
                </div>
                
                <div class="item-desc">Increased respiratory rate, especially during an asthma attack</div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/31662445" target="_blank">PMID:31662445</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Asthma severity was dependent on variety of symptoms, consisting mostly of wheezing, breathlessness, chest tightness, and cough."</div>
                
                
                <div class="evidence-explanation">The study mentions breathlessness as a common symptom of asthma, which can be associated with rapid breathing, especially during an asthma attack.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/27576231" target="_blank">PMID:27576231</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Asthma is a chronic respiratory disease characterized by chronic airway inflammation and variable expiratory airflow limitation. Related clinical features include wheezing, dyspnea, chest tightness, and cough that worsens at night or in the early morning, and that varies over time and in intensity."</div>
                
                
                <div class="evidence-explanation">Dyspnea, which is mentioned as a related clinical feature of asthma, can be associated with rapid breathing.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Cyanosis
                    
                    <span class="phenotype-freq">OCCASIONAL</span>
                    
                    
                    <span class="phenotype-category">Respiratory</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="https://hpo.jax.org/browse/term/HP:0000961" target="_blank">
                            HP:0000961
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Bluish discoloration of skin and mucous membranes due to low oxygen</div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/29601558" target="_blank">PMID:29601558</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                </div>
                
                <div class="evidence-snippet">"Dyspnea as a subjective feeling of lack of air is the patients with the pathology of the respiratory system. Objectivization of this phenomenon is difficult, despite the introduction of questionnaires about the degree of dyspnoea. The results of these assessments do not always correlate with the..."</div>
                
                
                <div class="evidence-explanation">While this reference discusses dyspnea in asthma patients, it does not explicitly mention cyanosis. However, dyspnea and airway obstruction could potentially lead to cyanosis in severe cases.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Fatigue
                    
                    <span class="phenotype-freq">FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Systemic</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="https://hpo.jax.org/browse/term/HP:0012378" target="_blank">
                            HP:0012378
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Due to increased work of breathing and sleep disturbance</div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/33783133" target="_blank">PMID:33783133</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Fatigue as a symptom is common in asthmatic patients and correlates with asthma-related quality of life, asthma control, dyspnea, depression and anxiety."</div>
                
                
                <div class="evidence-explanation">The study indicates that fatigue is a common symptom in asthmatic patients and is associated with various aspects of asthma, supporting the statement that fatigue is frequent in asthma.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/33783133" target="_blank">PMID:33783133</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                </div>
                
                <div class="evidence-snippet">"Future studies are needed to better understand the physical, psychological, behavioural and systemic factors that precipitate or perpetuate fatigue in asthma."</div>
                
                
                <div class="evidence-explanation">While the study supports the association of fatigue with asthma, it does not explicitly confirm that the increased work of breathing and sleep disturbance are the causes of fatigue, hence the partial support.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Exercise Intolerance
                    
                    <span class="phenotype-freq">FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Activity</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="https://hpo.jax.org/browse/term/HP:0003546" target="_blank">
                            HP:0003546
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Worsening of asthma symptoms with physical activity</div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (5 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/8088098" target="_blank">PMID:8088098</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Given sufficient exercise intensity, exercise can trigger acute exacerbations in virtually all individuals with asthma."</div>
                
                
                <div class="evidence-explanation">The literature indicates that exercise can trigger asthma symptoms in individuals with asthma, supporting the statement that exercise intolerance is frequent in asthma patients.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/31662445" target="_blank">PMID:31662445</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Asthma severity was dependent on variety of symptoms, consisting mostly of wheezing, breathlessness, chest tightness, and cough."</div>
                
                
                <div class="evidence-explanation">The study highlights that physical activity can exacerbate asthma symptoms such as wheezing and breathlessness, indicating exercise intolerance.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/34536613" target="_blank">PMID:34536613</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"PA can trigger asthma symptoms."</div>
                
                
                <div class="evidence-explanation">The literature confirms that physical activity can trigger asthma symptoms, supporting the statement about exercise intolerance.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 2 more references</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Sleep Disturbance
                    
                    <span class="phenotype-freq">FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Sleep</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="https://hpo.jax.org/browse/term/HP:0002360" target="_blank">
                            HP:0002360
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Nocturnal asthma can cause nighttime coughing and difficulty sleeping</div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (5 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/11990234" target="_blank">PMID:11990234</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Nocturnal airway narrowing in asthma is often associated with sleep disorders, such as episodes of nocturnal and early morning awakening, difficulty in maintaining sleep, and day time sleepiness."</div>
                
                
                <div class="evidence-explanation">This reference supports the statement by indicating that nocturnal asthma is associated with sleep disturbances, including difficulty in maintaining sleep.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/31541769" target="_blank">PMID:31541769</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"CoFr during nighttime (asleep) was significantly higher in asthmatic patients than in nonasthmatic patients."</div>
                
                
                <div class="evidence-explanation">This reference supports the statement by showing that nighttime cough frequency is higher in asthmatic patients, which implies sleep disturbances.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/19823913" target="_blank">PMID:19823913</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Sleep disruption is common in patients with cough and is often the reason why they seek medical attention."</div>
                
                
                <div class="evidence-explanation">This reference supports the statement by indicating that sleep disruption is common in patients with chronic cough, which includes those with asthma.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 2 more references</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Anxiety
                    
                    <span class="phenotype-freq">OCCASIONAL</span>
                    
                    
                    <span class="phenotype-category">Systemic</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="https://hpo.jax.org/browse/term/HP:0000739" target="_blank">
                            HP:0000739
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Asthma attacks can be frightening and cause anxiety about future episodes</div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/10868701" target="_blank">PMID:10868701</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Both the attacks themselves and the prospect of attacks generate much anxiety amongst patients."</div>
                
                
                <div class="evidence-explanation">The reference explains that asthma attacks and the anticipation of such attacks can generate significant anxiety among patients, supporting the statement that asthma can occasionally cause anxiety.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/32720730" target="_blank">PMID:32720730</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Asthma was significantly associated with anxiety in boys, particularly in older boys."</div>
                
                
                <div class="evidence-explanation">This study found a significant association between asthma and anxiety in boys, further supporting the statement that asthma can occasionally cause anxiety.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/35278300" target="_blank">PMID:35278300</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Another aspect is the relationship of bronchial asthma with the development of mood disorders."</div>
                
                
                <div class="evidence-explanation">The reference mentions the relationship between bronchial asthma and mood disorders, including anxiety, supporting the statement.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Respiratory Distress
                    
                    <span class="phenotype-freq">FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Respiratory</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="https://hpo.jax.org/browse/term/HP:0002098" target="_blank">
                            HP:0002098
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Reduced Exercise Tolerance
                    
                    <span class="phenotype-freq">FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Cardiovascular</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="https://hpo.jax.org/browse/term/HP:0003546" target="_blank">
                            HP:0003546
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    
            </div>
            
        </div>
        

        <!-- Genetic Associations -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #dbeafe; color: #2563eb;">🧬</div>
                <h2 class="card-title">Genetic Associations</h2>
                <span class="card-count">6</span>
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    IL4
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Associated)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/23070918" target="_blank">PMID:23070918</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"The results indicated that there were an association between the IL-4 C-33T (P = 0.006) and C-589T (P = 0.04) ... and susceptibility to asthma."</div>
                
                
                <div class="evidence-explanation">This meta-analysis found a significant association between IL-4 polymorphisms (C-33T and C-589T) and asthma susceptibility.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/10073323" target="_blank">PMID:10073323</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Using both the candidate gene and the positional cloning approaches, there is evidence that predisposing factors, if not the disease itself, are genetically transferred."</div>
                
                
                <div class="evidence-explanation">This reference generally supports the idea of genetic associations in asthma, including those likely involving IL-4.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/21325943" target="_blank">PMID:21325943</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                </div>
                
                <div class="evidence-snippet">"Genotype combinations of IL-4 receptor-alpha and CD14 single nucleotide polymorphisms (SNPs) were significantly associated with diisocyanate asthma."</div>
                
                
                <div class="evidence-explanation">This study refers to IL-4 receptor-alpha and not IL-4 directly, and its context is specific to occupational asthma caused by diisocyanate exposure.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    IL13
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Associated)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/23996716" target="_blank">PMID:23996716</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Interleukin-13 (IL-13) is known to be a key regulator in immunoglobulin E (IgE) synthesis, mucus hypersecretion and airway hyperresponsiveness... A statistically significant association of the A-1512C polymorphism in IL13 gene was observed with atopy."</div>
                
                
                <div class="evidence-explanation">The study provides evidence that the IL13 gene polymorphism A-1512C is significantly associated with asthma.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/30539779" target="_blank">PMID:30539779</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                </div>
                
                <div class="evidence-snippet">"An efficient memory Th2 cell response is dependent on IL-13 produced by ILC2s, causing allergic lung inflammation and elevated serum levels of immunoglobulin E."</div>
                
                
                <div class="evidence-explanation">The study indicates that IL-13 is involved in allergic lung inflammation which is relevant to asthma, but it primarily discusses IL-13&#39;s role in mediating immune responses rather than directly associating IL-13 genetic polymorphisms with asthma.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/23380221" target="_blank">PMID:23380221</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                </div>
                
                <div class="evidence-snippet">"Very recently, a novel population of IL-33-responsive innate immune cells, the type 2 innate lymphoid cells, was found to produce hallmark TH2 cytokines, such as IL-5 and IL-13."</div>
                
                
                <div class="evidence-explanation">The review highlights the role of IL-13 in the pathway involved in asthma pathogenesis but does not directly establish a genetic association between IL-13 and asthma.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    ADAM33
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Associated)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/26666372" target="_blank">PMID:26666372</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"A disintegrin and metalloproteinase 33 (ADAM33) gene has been considered as an asthma susceptibility gene due to its possible role in airway remodeling, abnormal cell proliferation, and differentiation. Association of this gene with asthma has been reported in several genetic studies on various..."</div>
                
                
                <div class="evidence-explanation">This study and its findings directly support the statement about the association between the ADAM33 gene and asthma.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/19481925" target="_blank">PMID:19481925</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Despite this, the field has identified 43 replicated genes from association studies. The most frequently replicated are: TNF alpha, IL4, FCERB, Adam 33, and GSTP1."</div>
                
                
                <div class="evidence-explanation">This study acknowledges the genetic association between ADAM33 and asthma among other genes, further supporting the statement.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    GSDMB
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Associated)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/33963941" target="_blank">PMID:33963941</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Our results revealed that polymorphic variants rs7216389, rs2290400 and rs2305480 are associated with the development of allergic diseases as well as with asthma and asthma combined with allergic rhinitis."</div>
                
                
                <div class="evidence-explanation">This reference specifically mentions GSDMB polymorphisms and their association with asthma.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    HLA-DQ
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Associated)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/23181788" target="_blank">PMID:23181788</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Overall, our findings further replicate the HLA-DQ region in the pathogenesis of asthma."</div>
                
                
                <div class="evidence-explanation">The study highlights the association of HLA-DQ genes, specifically HLA-DQA1, with asthma in adults, corroborating previous findings linking HLA-DQ to asthma susceptibility.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    ORMDL3
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Associated)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/25167772" target="_blank">PMID:25167772</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"The results of this meta-analysis firmly established that genetic variation at the rs7216389 locus, which controls the expression of the ORMDL3, may be a major, independent predisposing factor for asthma in ethnically diverse populations."</div>
                
                
                <div class="evidence-explanation">The meta-analysis confirms the association between the ORMDL3 gene and asthma susceptibility.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/18754760" target="_blank">PMID:18754760</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                </div>
                
                <div class="evidence-snippet">"It is far from being clear which gene caused the association signal, as it is derived from a large linkage disequilibrium (LD) block."</div>
                
                
                <div class="evidence-explanation">The study suggests an association signal that includes ORMDL3 but indicates uncertainty about the specific gene responsible due to a large LD block.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/21276132" target="_blank">PMID:21276132</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"The first GWAS for asthma discovered a novel associated locus on chromosome 17q21 encompassing the genes ORMDL3, GSDMB and ZPBP2."</div>
                
                
                <div class="evidence-explanation">This GWAS identifies ORMDL3 as part of a locus associated with asthma.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Treatments -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #ede9fe; color: #7c3aed;">💊</div>
                <h2 class="card-title">Treatments</h2>
                <span class="card-count">5</span>
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Inhaled Corticosteroid
                    
                    <span class="phenotype-id">
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/maxo/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FMAXO_0000312" target="_blank">
                            MAXO:0000312
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Reduce inflammation and prevent flare-ups.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/22559870" target="_blank">PMID:22559870</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Current guidelines recommend long-term treatment with inhaled corticosteroids (ICS) because of their superior effectiveness in managing the chronic airway inflammation that characterizes persistent asthma."</div>
                
                
                <div class="evidence-explanation">This literature supports the statement that inhaled corticosteroids reduce inflammation in asthma.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/9817746" target="_blank">PMID:9817746</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Glucocorticoids are highly effective in the control of asthma and suppression of airway inflammation."</div>
                
                
                <div class="evidence-explanation">This reference supports the role of glucocorticoids, which includes inhaled corticosteroids, in reducing airway inflammation in asthma.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/32868307" target="_blank">PMID:32868307</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"The 2019 Global Initiative for Asthma (GINA) guidelines recommend that all asthma patients be treated with inhaled corticosteroids taken daily or as needed; this improves symptoms and outcomes, even in those with mild disease."</div>
                
                
                <div class="evidence-explanation">This guideline indicates that inhaled corticosteroids are recommended for improving asthma outcomes, supporting their role in preventing flare-ups.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Long-acting Beta Agonist
                    
                    <span class="phenotype-id">
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/maxo/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FMAXO_0000312" target="_blank">
                            MAXO:0000312
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Relax the muscles around the airways.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/34753370" target="_blank">PMID:34753370</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Patients experience significant clinical benefits from therapy with long-acting β2-agonists (LABAs) with efficacy to bronchodilate, and prolonged lung function betterment."</div>
                
                
                <div class="evidence-explanation">The literature supports that LABAs help in relaxing the muscles around the airways, thereby improving lung function and providing symptomatic relief in asthma management.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/37489386" target="_blank">PMID:37489386</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Long-acting muscarinic antagonists (LAMAs) are a class of inhalers that has recently been included as add-on therapy in the GINA guidelines, either in a single inhaler device with inhaled corticosteroids plus long-acting beta2-agonists (ICS + LABA)."</div>
                
                
                <div class="evidence-explanation">Although primarily about LAMAs, the literature acknowledges that LABAs are part of the recommended treatment regimen for asthma, which implies their role in relaxing airway muscles.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/32306788" target="_blank">PMID:32306788</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Contemporary mainstay therapies (inhaled corticosteroids and bronchodilators), prescribed empirically, control symptoms resulting from airways obstruction tolerably well in many patients..."</div>
                
                
                <div class="evidence-explanation">The literature indicates that LABAs, as bronchodilators, help control symptoms related to airway obstruction by relaxing the airway muscles.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Leukotriene Modifier
                    
                    <span class="phenotype-id">
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/maxo/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FMAXO_0000312" target="_blank">
                            MAXO:0000312
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Reduce inflammation, decrease mucus secretion, and prevent airway constriction.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/14720013" target="_blank">PMID:14720013</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Leukotriene modifiers increase the therapeutic options for patients with asthma and, based on recent data, it is expected that future guidelines will describe expanded uses for these agents in clinical circumstances where these drugs are effective."</div>
                
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/11085767" target="_blank">PMID:11085767</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Their unique mechanism of action results in a combination of both bronchodilator and anti-inflammatory effects."</div>
                
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/19180262" target="_blank">PMID:19180262</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Cysteinyl leukotrienes, which are derivatives of the 5-lipoxygenase pathway of arachidonic acid metabolism, are important mediators of airway allergic inflammation and have a role in the pathogenetic mechanism of EIB. Montelukast sodium (Singulair, Merck &amp; Co.) is a selective and orally active..."</div>
                
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Anti-IgE Therapy
                    
                    <span class="phenotype-id">
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/maxo/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FMAXO_0000312" target="_blank">
                            MAXO:0000312
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Used to treat severe allergic asthma by blocking IgE, a key chemical in the allergic response.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/29427989" target="_blank">PMID:29427989</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Severe allergic asthma and severe eosinophilic asthma are two defined phenotypes for which there are efficacious targeted biologic therapies currently available, namely anti-immunoglobulin E (IgE) and anti-interleukin (IL)-5 antibodies, respectively."</div>
                
                
                <div class="evidence-explanation">This reference confirms that anti-IgE therapy is used to treat severe allergic asthma.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/20799475" target="_blank">PMID:20799475</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Among these is anti-IgE, which directly targets IgE serum antibodies, thus inhibiting the central mechanism of immediate type hypersensitivity reactions. Application of anti-IgE antibodies effectively reduces IgE serum levels regardless of allergen specificity."</div>
                
                
                <div class="evidence-explanation">This reference supports that anti-IgE therapy is used in allergic asthma by targeting and reducing IgE.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/28635659" target="_blank">PMID:28635659</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Blocking IgE with monoclonal antibodies such as omalizumab have demonstrated their efficacy, effectiveness, and safety in treating allergic asthma."</div>
                
                
                <div class="evidence-explanation">This reference confirms that anti-IgE therapy, specifically using omalizumab, is effective in treating allergic asthma.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Short-acting Beta Agonist
                    
                    <span class="phenotype-id">
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/maxo/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FMAXO_0000312" target="_blank">
                            MAXO:0000312
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Provides rapid relief from acute asthma symptoms.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (5 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/34369231" target="_blank">PMID:34369231</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Albuterol is the most common fast acting medication for asthma, and it exists in multiple forms, including metered-dose inhaler and nebulized therapy."</div>
                
                
                <div class="evidence-explanation">Albuterol, a commonly used short-acting beta agonist, is indicated as a fast-acting medication for the relief of asthma symptoms.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/30297688" target="_blank">PMID:30297688</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Initial therapy in the stepwise approach for asthma management is short-acting β₂-agonist (SABA) therapy as needed for symptom control."</div>
                
                
                <div class="evidence-explanation">Short-acting beta agonists are recommended as initial therapy for the control of asthma symptoms, indicating their rapid relief properties.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/27588581" target="_blank">PMID:27588581</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Results demonstrate the efficacy of short-acting beta-agonist (SABA) delivered by metered-dose inhaler as first-line therapy for younger and older children."</div>
                
                
                <div class="evidence-explanation">The efficacy of SABAs as a first-line therapy in emergency asthma management highlights their role in providing rapid relief from acute asthma symptoms.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 2 more references</div>
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Environmental Factors -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #ccfbf1; color: #0d9488;">🌍</div>
                <h2 class="card-title">Environmental Factors</h2>
                <span class="card-count">4</span>
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">Allergens</div>
                
                <div class="item-desc">Triggering factor for allergic asthma</div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (9 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/26788835" target="_blank">PMID:26788835</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                </div>
                
                <div class="evidence-snippet">"Persons with asthma and multiple diagnoses reported odorous/pungent and building-related environmental factors to trigger symptoms to a larger extent than did the reference group, mainly due to perfume and odors from flowers."</div>
                
                
                <div class="evidence-explanation">This supports the role of environmental factors in triggering symptoms in people with asthma but does not specifically address allergens as a triggering factor.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/29732974" target="_blank">PMID:29732974</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"The link between asthma and food allergy has been well researched over the years; although the exact interplay between the two atopic conditions is yet to be fully described. Research suggests that children who have both asthma and food allergy are at greater risk of more severe asthmatic episodes."</div>
                
                
                <div class="evidence-explanation">This supports the idea that allergens (specifically food allergies) can trigger severe asthma attacks.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/20406590" target="_blank">PMID:20406590</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"A complex interplay of genetic predisposition and environmental influences results in the clinical picture of allergic asthma."</div>
                
                
                <div class="evidence-explanation">This supports the role of environmental influences, which includes allergens, in allergic asthma.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 6 more references</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">Air Pollution</div>
                
                <div class="item-desc">Exacerbates symptoms</div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (6 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/10518814" target="_blank">PMID:10518814</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Air pollution is convincingly associated with many signs of asthma aggravation."</div>
                
                
                <div class="evidence-explanation">The article states that air pollution is associated with various signs and symptoms of asthma aggravation, supporting the statement that air pollution exacerbates asthma symptoms.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/21277508" target="_blank">PMID:21277508</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Extrinsic factors include environmental exposure to temperature, humidity, aeroallergens, irritants, and pollution."</div>
                
                
                <div class="evidence-explanation">The article discusses how environmental factors, including pollution, can result in impaired function of the airways of athletes, which supports the statement.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/31187658" target="_blank">PMID:31187658</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Increases in mold and PM10 were associated with increases in asthma claims."</div>
                
                
                <div class="evidence-explanation">The study found associations between particulate pollution and increased asthma claims, supporting the statement.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 3 more references</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">Tobacco Smoke</div>
                
                <div class="item-desc">Major risk factor for symptom severity</div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (5 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/25584912" target="_blank">PMID:25584912</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Exposure to passive smoke as a risk factor for asthma onset in childhood."</div>
                
                
                <div class="evidence-explanation">The study highlights how environmental tobacco smoke (ETS) is a significant indoor pollutant and a likely cause for asthma onset and severity in childhood.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/29292313" target="_blank">PMID:29292313</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Exposure to environmental tobacco smoke increases pediatric asthma severity."</div>
                
                
                <div class="evidence-explanation">The study found that higher state tax grades on tobacco were associated with reduced asthma severity, indicating the detrimental impact of tobacco smoke on asthma severity.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/35236762" target="_blank">PMID:35236762</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                </div>
                
                <div class="evidence-snippet">"We aimed to study the associations between particulate matter with an aerodynamic diameter lower than 2.5 µm (PM2.5), black carbon (BC) and NO2 and the asthma symptom score in adults."</div>
                
                
                <div class="evidence-explanation">The study focuses on various air pollutants but does not specifically address tobacco smoke as an environmental factor affecting asthma severity.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 2 more references</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">Occupational Exposures</div>
                
                <div class="item-desc">Exposure to dust, chemicals, or gases in the workplace can trigger asthma symptoms.</div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (6 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/15579371" target="_blank">PMID:15579371</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"The prevalence of occupational asthma is rising, possibly due to the introduction of different chemicals and substances in the workplace. Etiologic agents include organic and inorganic compounds that are encountered in a variety of industries."</div>
                
                
                <div class="evidence-explanation">This reference explicitly states that occupational exposures to chemicals and substances in the workplace can trigger asthma.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/33104273" target="_blank">PMID:33104273</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Dentists are exposed to a variety of airborne chemicals that can act as irritants and sensitizers and may give rise to work-related respiratory symptoms."</div>
                
                
                <div class="evidence-explanation">This supports the statement by indicating that occupational exposure to airborne chemicals can lead to respiratory symptoms including asthma.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/37971937" target="_blank">PMID:37971937</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Multiple respiratory hazards have been identified in the cannabis cultivation and production industry, in which occupational asthma and work-related exacerbation of preexisting asthma have been reported."</div>
                
                
                <div class="evidence-explanation">This reference highlights occupational asthma caused by exposure to respiratory hazards in the cannabis industry.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 3 more references</div>
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Biochemical Markers -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">🔬</div>
                <h2 class="card-title">Biochemical Markers</h2>
                <span class="card-count">3</span>
            </div>
            
            <div class="item-box biochemical-box">
                <div class="item-name">
                    Eosinophils
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Elevated)</span>
                    
                </div>
                
                <div class="item-desc">Context: allergic asthma</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (5 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/27401626" target="_blank">PMID:27401626</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                </div>
                
                <div class="evidence-snippet">"Asthma is a heterogeneous disease that can be classified into different clinical endotypes, depending on the type of airway inflammation, clinical severity, and response to treatment. This article focuses on the eosinophilic endotype of asthma, which is defined by the central role that..."</div>
                
                
                <div class="evidence-explanation">The reference supports that eosinophils are elevated in eosinophilic asthma, but does not specifically mention the allergic asthma subtype.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/30303258" target="_blank">PMID:30303258</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"There was a significantly higher serum IL-33 level in the eosinophilic asthma group when compared to the group of non-eosinophilic asthma patients (1001.10 +/- 199.11 pg/mL vs 337.49 +/- 72.68 pg/mL, P &lt; 0.01)."</div>
                
                
                <div class="evidence-explanation">The reference mentions a higher level of eosinophils in eosinophilic asthma, which can be associated with allergic asthma.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/31944632" target="_blank">PMID:31944632</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                </div>
                
                <div class="evidence-snippet">"Elevated FeNO in nonasthmatic adolescents was associated with airway hyperresponsiveness, elevated blood eosinophil counts, and lower systemic activation of neutrophils."</div>
                
                
                <div class="evidence-explanation">This reference supports elevated eosinophils but focuses on nonasthmatic adolescents rather than allergic asthma specifically.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 2 more references</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box biochemical-box">
                <div class="item-name">
                    Neutrophils
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Elevated)</span>
                    
                </div>
                
                <div class="item-desc">Context: non-allergic asthma</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/33830849" target="_blank">PMID:33830849</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Neutrophilic asthma is associated with poorer responses to classic therapies, namely (inhaled) corticosteroids."</div>
                
                
                <div class="evidence-explanation">The document discusses neutrophilic asthma, a subtype of asthma characterized by elevated neutrophils, indicating that neutrophils are indeed elevated in some forms of asthma, including non-allergic ones.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/28163052" target="_blank">PMID:28163052</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"RA was associated with increased numbers of neutrophils and proneutrophilic biomolecules in the airways."</div>
                
                
                <div class="evidence-explanation">This reference supports the statement by indicating that refractory asthma, which often overlaps with non-allergic asthma, is associated with elevated neutrophils.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/36871881" target="_blank">PMID:36871881</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Corticosteroid resistance, progressive lung function decline, and frequent asthma exacerbations are the hallmarks of neutrophilic asthma (NA)."</div>
                
                
                <div class="evidence-explanation">The study highlights neutrophilic asthma, a type often linked with non-allergic inflammatory processes, which supports the elevation of neutrophils in such asthma subtypes.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box biochemical-box">
                <div class="item-name">
                    IgE Antibodies
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Elevated)</span>
                    
                </div>
                
                <div class="item-desc">Context: allergic reactions</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (5 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/33479910" target="_blank">PMID:33479910</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"However, the immunoglobulin E (IgE) antibody is necessary for the initiation of the allergic cascade, and IgE is produced and released exclusively by memory B cells and plasma cells. Acute allergen exposure has also been shown to increase IgE levels in the airways of patients diagnosed with..."</div>
                
                
                <div class="evidence-explanation">The text indicates that IgE antibodies are necessary for the allergic cascade in asthma and are elevated after acute allergen exposure.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/20406591" target="_blank">PMID:20406591</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"As many as 90-95% of patients with asthma have aeroallergen sensitization and the pattern varies with ethnicity, location of residence, and onset of asthma, but not age."</div>
                
                
                <div class="evidence-explanation">The reference mentions higher levels of IgE are common in patients with asthma and aeroallergen sensitization.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/27264001" target="_blank">PMID:27264001</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"However, there are syndromes in which the relationship between exposure to the relevant allergen and the &#39;allergic&#39; disease is not clear. In these cases the presence of specific IgE antibodies can play an important role in identifying the relevant allergen and provide a guide to therapy. Good..."</div>
                
                
                <div class="evidence-explanation">Elevated IgE antibodies play a role in chronic asthma and identifying relevant allergens, supporting the statement.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 2 more references</div>
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Differential Diagnoses -->
        

        <!-- Datasets -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #e0f2fe; color: #0284c7;">📊</div>
                <h2 class="card-title">Related Datasets</h2>
                <span class="card-count">6</span>
            </div>
            
            <div class="item-box dataset-box">
                <div class="item-name">
                    Airway epithelial gene expression in asthma versus healthy controls
                    
                    <span class="dataset-accession">
                        <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE67472" target="_blank">geo:GSE67472</a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Bronchial epithelial brushings from mild-to-moderate asthmatics (not on inhaled steroids) and healthy controls, stratified by Type 2 inflammation markers (POSTN, SERPINB2, CLCA1).</div>
                
                <div class="item-meta">
                    
                    <span class="tag tag-organism">human</span>
                    
                    
                    <span class="tag tag-datatype">MICROARRAY</span>
                    
                    
                    <span class="tag tag-dataset">n=105</span>
                    
                    
                    <span class="tag" style="background: #f1f5f9; color: #475569;">Affymetrix Human Genome U133 Plus 2.0</span>
                    
                </div>
                
                <div class="item-meta" style="margin-top: 6px;">
                    
                    <span class="tag tag-cell">
                        bronchial epithelial cells
                        
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0002328" target="_blank" style="color: inherit; margin-left: 4px;">↗</a>
                        
                    </span>
                    
                </div>
                
                
                <div class="item-meta" style="margin-top: 6px;">
                    <strong style="font-size: 0.8rem; color: #0369a1;">Conditions:</strong>
                    
                    <span class="tag" style="background: #f0f9ff; color: #0369a1; font-size: 0.8rem;">mild-to-moderate asthma (n=62)</span>
                    
                    <span class="tag" style="background: #f0f9ff; color: #0369a1; font-size: 0.8rem;">healthy controls (n=43)</span>
                    
                </div>
                
                
                
                <div style="margin-top: 8px; font-size: 0.85rem;">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/25611785" target="_blank" style="color: var(--secondary);">PMID:25611785</a>
                </div>
                
                
                <div class="item-desc" style="margin-top: 8px; font-style: italic;">Identifies Type 2 inflammation gene signature. Useful for studying eosinophilic asthma endotypes.</div>
                
                
    
    
            </div>
            
            <div class="item-box dataset-box">
                <div class="item-name">
                    Asthma II
                    
                    <span class="dataset-accession">
                        <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE63142" target="_blank">geo:GSE63142</a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Bronchial epithelial cells from normal controls, mild-moderate, and severe asthmatic patients to identify severity-associated gene expression.</div>
                
                <div class="item-meta">
                    
                    <span class="tag tag-organism">human</span>
                    
                    
                    <span class="tag tag-datatype">MICROARRAY</span>
                    
                    
                    <span class="tag tag-dataset">n=155</span>
                    
                    
                    <span class="tag" style="background: #f1f5f9; color: #475569;">Agilent Whole Human Genome Microarray 4x44K</span>
                    
                </div>
                
                <div class="item-meta" style="margin-top: 6px;">
                    
                    <span class="tag tag-cell">
                        bronchial epithelial cells
                        
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0002328" target="_blank" style="color: inherit; margin-left: 4px;">↗</a>
                        
                    </span>
                    
                </div>
                
                
                <div class="item-meta" style="margin-top: 6px;">
                    <strong style="font-size: 0.8rem; color: #0369a1;">Conditions:</strong>
                    
                    <span class="tag" style="background: #f0f9ff; color: #0369a1; font-size: 0.8rem;">severe asthma (n=56)</span>
                    
                    <span class="tag" style="background: #f0f9ff; color: #0369a1; font-size: 0.8rem;">mild-moderate asthma (n=72)</span>
                    
                    <span class="tag" style="background: #f0f9ff; color: #0369a1; font-size: 0.8rem;">healthy controls (n=27)</span>
                    
                </div>
                
                
                
                
                
    
    
            </div>
            
            <div class="item-box dataset-box">
                <div class="item-name">
                    Transcriptomic profiles of the nasal epithelium from the Genes-environments &amp; Admixture in Latino Americans (GALA) II study
                    
                    <span class="dataset-accession">
                        <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE152004" target="_blank">geo:GSE152004</a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Large cohort study of nasal epithelial cells comparing asthmatic and control subjects.</div>
                
                <div class="item-meta">
                    
                    <span class="tag tag-organism">human</span>
                    
                    
                    <span class="tag tag-datatype">MICROARRAY</span>
                    
                    
                    <span class="tag tag-dataset">n=393</span>
                    
                    
                </div>
                
                <div class="item-meta" style="margin-top: 6px;">
                    
                    <span class="tag tag-cell">
                        nasal epithelial cells
                        
                    </span>
                    
                </div>
                
                
                <div class="item-meta" style="margin-top: 6px;">
                    <strong style="font-size: 0.8rem; color: #0369a1;">Conditions:</strong>
                    
                    <span class="tag" style="background: #f0f9ff; color: #0369a1; font-size: 0.8rem;">asthma (n=257)</span>
                    
                    <span class="tag" style="background: #f0f9ff; color: #0369a1; font-size: 0.8rem;">controls (n=136)</span>
                    
                </div>
                
                
                
                
                
    
    
            </div>
            
            <div class="item-box dataset-box">
                <div class="item-name">
                    Epithelial miR-141 regulates IL-13-induced airway mucus production [single-cell RNA-seq]
                    
                    <span class="dataset-accession">
                        <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE164015" target="_blank">geo:GSE164015</a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Single-cell RNA sequencing of airway epithelial cells from asthmatic patients revealing cell-type specific transcriptional changes.</div>
                
                <div class="item-meta">
                    
                    <span class="tag tag-organism">human</span>
                    
                    
                    <span class="tag tag-datatype">SINGLE CELL RNA SEQ</span>
                    
                    
                    
                </div>
                
                <div class="item-meta" style="margin-top: 6px;">
                    
                    <span class="tag tag-cell">
                        airway epithelial cells
                        
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0002202" target="_blank" style="color: inherit; margin-left: 4px;">↗</a>
                        
                    </span>
                    
                </div>
                
                
                <div class="item-meta" style="margin-top: 6px;">
                    <strong style="font-size: 0.8rem; color: #0369a1;">Conditions:</strong>
                    
                    <span class="tag" style="background: #f0f9ff; color: #0369a1; font-size: 0.8rem;">asthmatic patients</span>
                    
                </div>
                
                
                
                
                <div class="item-desc" style="margin-top: 8px; font-style: italic;">Reveals cell-type specific heterogeneity in asthmatic airways</div>
                
                
    
    
            </div>
            
            <div class="item-box dataset-box">
                <div class="item-name">
                    Molecular impact of electronic cigarette aerosol exposure in human bronchial epithelium
                    
                    <span class="dataset-accession">
                        <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE82137" target="_blank">geo:GSE82137</a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Primary human bronchial epithelial cells grown at air-liquid interface, exposed to whole tobacco cigarette smoke and electronic cigarette aerosol.</div>
                
                <div class="item-meta">
                    
                    <span class="tag tag-organism">human</span>
                    
                    
                    <span class="tag tag-datatype">MICROARRAY</span>
                    
                    
                    
                </div>
                
                <div class="item-meta" style="margin-top: 6px;">
                    
                    <span class="tag tag-cell">
                        primary bronchial epithelial cells (ALI culture)
                        
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0002328" target="_blank" style="color: inherit; margin-left: 4px;">↗</a>
                        
                    </span>
                    
                </div>
                
                
                <div class="item-meta" style="margin-top: 6px;">
                    <strong style="font-size: 0.8rem; color: #0369a1;">Conditions:</strong>
                    
                    <span class="tag" style="background: #f0f9ff; color: #0369a1; font-size: 0.8rem;">tobacco cigarette smoke (48 puffs)</span>
                    
                    <span class="tag" style="background: #f0f9ff; color: #0369a1; font-size: 0.8rem;">e-cigarette aerosol (menthol flavor, +/- nicotine)</span>
                    
                    <span class="tag" style="background: #f0f9ff; color: #0369a1; font-size: 0.8rem;">e-cigarette aerosol (tobacco flavor, +/- nicotine)</span>
                    
                    <span class="tag" style="background: #f0f9ff; color: #0369a1; font-size: 0.8rem;">control</span>
                    
                </div>
                
                
                <div class="item-meta" style="margin-top: 6px;">
                    <strong style="font-size: 0.8rem; color: #0d9488;">Exposures:</strong>
                    
                    <span class="tag tag-env">
                        tobacco smoke exposure
                        
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/ecto/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FECTO_6000029" target="_blank" style="color: inherit; margin-left: 4px;">↗</a>
                        
                    </span>
                    
                </div>
                
                
                
                <div class="item-desc" style="margin-top: 8px; font-style: italic;">Compares traditional vs electronic cigarette effects on airway epithelium</div>
                
                
    
    
            </div>
            
            <div class="item-box dataset-box">
                <div class="item-name">
                    Gene expression profiling of experimental asthma reveals a possible role of paraoxonase-1 in asthma
                    
                    <span class="dataset-accession">
                        <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE11911" target="_blank">geo:GSE11911</a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Gene expression from lung tissue of ovalbumin-sensitized and challenged BALB/c mice modeling allergic airway inflammation.</div>
                
                <div class="item-meta">
                    
                    <span class="tag tag-organism">mouse</span>
                    
                    
                    <span class="tag tag-datatype">MICROARRAY</span>
                    
                    
                    
                </div>
                
                <div class="item-meta" style="margin-top: 6px;">
                    
                    <span class="tag tag-cell">
                        whole lung tissue
                        
                    </span>
                    
                </div>
                
                
                <div class="item-meta" style="margin-top: 6px;">
                    <strong style="font-size: 0.8rem; color: #0369a1;">Conditions:</strong>
                    
                    <span class="tag" style="background: #f0f9ff; color: #0369a1; font-size: 0.8rem;">OVA-sensitized and challenged</span>
                    
                    <span class="tag" style="background: #f0f9ff; color: #0369a1; font-size: 0.8rem;">control</span>
                    
                </div>
                
                
                <div class="item-meta" style="margin-top: 6px;">
                    <strong style="font-size: 0.8rem; color: #0d9488;">Exposures:</strong>
                    
                    <span class="tag tag-env">
                        ovalbumin allergen challenge
                        
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/ecto/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FECTO_0000726" target="_blank" style="color: inherit; margin-left: 4px;">↗</a>
                        
                    </span>
                    
                </div>
                
                
                
                <div class="item-desc" style="margin-top: 8px; font-style: italic;">Classic murine allergic airway inflammation model</div>
                
                
    
    
            </div>
            
        </div>
        

        <!-- YAML Source -->
        <div class="card">
            <div class="card-header" style="cursor: pointer;" onclick="toggleYaml()">
                <div class="card-icon" style="background: #f1f5f9; color: #475569;">{ }</div>
                <h2 class="card-title">Source YAML</h2>
                <span class="card-count" id="yamlToggleText">click to show</span>
            </div>
            <div class="yaml-content" id="yamlContent">
                <pre class="yaml-preview">name: Asthma
category: Complex
parents:
- Respiratory Disease
- Chronic Inflammatory Disease
has_subtypes:
- name: Allergic Asthma
  description: Triggered by allergens such as pollen, pet dander, or dust mites.
  evidence:
  - reference: PMID:32037107
    supports: SUPPORT
    snippet: Allergic asthma is defined as asthma associated with sensitization to
      aeroallergens, which leads to asthma symptoms and airway inflammation.
    explanation: The literature explicitly states that allergic asthma is triggered
      by allergens.
  - reference: PMID:24925403
    supports: SUPPORT
    snippet: Allergic diseases triggered by mite allergens include allergic rhinoconjunctivitis,
      asthma, atopic dermatitis and other skin diseases.
    explanation: This literature confirms asthma can be triggered by mite allergens,
      consistent with the definition of allergic asthma.
  - reference: PMID:32589303
    supports: SUPPORT
    snippet: Respiratory health can be particularly affected by climate change, which
      contributes to the development of allergic respiratory diseases and asthma.
    explanation: The document indicates that climate change contributes to the development
      of asthma, supporting the statement.
  - reference: PMID:30725285
    supports: SUPPORT
    snippet: Asthma is a heterogeneous chronic inflammatory disease of the airways.
      The most prevalent form is atopic asthma, which is initiated by the exposure
      to (inhaled) allergens.
    explanation: This literature identifies atopic (allergic) asthma as initiated
      by allergens, which supports the statement.
- name: Non-Allergic Asthma
  description: Triggered by factors such as stress, exercise, cold air, or respiratory
    infections.
  evidence:
  - reference: PMID:11678516
    supports: PARTIAL
    snippet: Asthmatic attack in exercise-induced asthma is brought about by hyperventilation
      (not necessarily to exercise), cold air, and low humidity of the air breathed.
    explanation: The reference discusses asthma subtypes triggered by exercise, cold
      air, and respiratory conditions, but does not explicitly mention stress or classify
      it specifically as &#39;Non-Allergic Asthma&#39;.
  - reference: PMID:25439356
    supports: PARTIAL
    snippet: First, asthma phenotypes that are associated with environmental exposures
      (occupational agents, cigarette smoke, air pollution, cold dry air)...
    explanation: The reference mentions environmental exposures like cold dry air
      and non-allergic triggers, but does not explicitly identify stress or exercise
      specifically in relation to &#39;Non-Allergic Asthma&#39;.
  - reference: PMID:20176257
    supports: SUPPORT
    snippet: Indoor and outdoor air pollutants trigger airway inflammation and increase
      the severity of asthma.
    explanation: The reference corroborates that environmental pollutants are triggers
      for asthma exacerbations.
- name: Adult-Onset Asthma
  description: Develops later in adult life and often triggered by environmental factors.
  evidence:
  - reference: PMID:36833767
    supports: SUPPORT
    snippet: Only a few previous studies have investigated the subtypes of adult-onset
      asthma. No previous study has assessed whether these subtypes are different
      between men and women, or whether these subtypes have different risk factors.
    explanation: The reference discusses subtypes of adult-onset asthma and emphasizes
      the importance of different risk factors, which supports that adult-onset asthma
      could have environmental triggers.
  - reference: PMID:30240884
    supports: SUPPORT
    snippet: Adult-onset asthma is an important asthma phenotype and, in contrast
      to childhood asthma, is often associated with specific triggers of onset.
    explanation: This study indicates that adult-onset asthma is often associated
      with specific triggers of onset, which aligns with the statement that it is
      often triggered by environmental factors.
  - reference: PMID:20176257
    supports: SUPPORT
    snippet: Exposure to unusual substances at work causes occupational asthma, accounting
      for about 5% of asthma in adults. Indoor and outdoor air pollutants trigger
      airway inflammation and increase the severity of asthma.
    explanation: The literature specifies that environmental factors such as pollutants
      can trigger adult asthma, further supporting the statement about environmental
      triggers.
- name: Asthma-COPD Overlap
  description: Features of both chronic obstructive pulmonary disease and asthma.
  evidence:
  - reference: PMID:26398072
    supports: SUPPORT
    snippet: Although in textbooks asthma and chronic obstructive pulmonary disease
      (COPD) are viewed as distinct disorders, there is increasing awareness that
      many patients have features of both. This article reviews the asthma-COPD overlap
      syndrome.
    explanation: The article explicitly refers to the Asthma-COPD Overlap Syndrome,
      which indicates the presence of subtypes sharing features of both asthma and
      COPD.
  - reference: PMID:24507842
    supports: SUPPORT
    snippet: Asthma in childhood and COPD in smokers have their own phenotypic expression
      with underlying pathophysiological mechanisms that differ importantly. In older
      adults, asthma and COPD are more difficult to differentiate and there exists
      a bronchodilator response in most but not all patients with asthma and persistent
      airway obstruction in most but not all patients with COPD where even up to 50%
      have been reported to have some bronchodilator response as assessed with FEV1.
    explanation: The article acknowledges overlapping phenotypes between asthma and
      COPD, supporting the existence of a subtype with features of both diseases.
  - reference: PMID:29713158
    supports: SUPPORT
    snippet: Asthma and COPD are heterogeneous diseases. Patients with both disease
      features (asthma-COPD overlap ...) are common.
    explanation: This article clearly supports that there is an overlap between asthma
      and COPD, validating the statement about the Asthma-COPD Overlap subtype with
      shared features.
- description: Often triggered by physical exertion.
  name: Exercise-Induced Asthma
  review_notes: Added Exercise-Induced Asthma for a more comprehensive list of subtypes.
  evidence:
  - reference: PMID:22794682
    supports: SUPPORT
    snippet: patients with asthma may be classified as allergic (IgE mediated), nonallergic
      (often triggered by viral upper respiratory tract infections or no apparent
      cause), occupational, aspirin-exacerbated respiratory disease, potentially (near)
      fatal, exercise induced, and cough variant asthma.
    explanation: This reference explicitly lists exercise-induced asthma as a subtype
      of asthma, supporting the statement.
  - reference: PMID:5002114
    supports: SUPPORT
    snippet: This study indicates that swimming should be recommended in preference
      to running or cycling as an exercise programme for adults and children with
      asthma.
    explanation: This study highlights exercise-induced asthma and provides insights
      into managing physical activities for those with this subtype.
  - reference: PMID:22157157
    supports: SUPPORT
    snippet: Exercise-induced bronchoconstriction (EIB) refers to acute airflow obstruction
      that is triggered by a period of physical exertion.
    explanation: This study details the pathology of exercise-induced bronchoconstriction,
      commonly referred to as exercise-induced asthma, supporting the statement.
  - reference: PMID:37086818
    supports: SUPPORT
    snippet: Exercise is one of the most commonly reported symptom triggers for people
      with asthma.
    explanation: This reference recognizes the role of physical exertion as a trigger
      for asthma symptoms, aligning with the concept of exercise-induced asthma as
      a subtype.
pathophysiology:
- name: Airway Inflammation
  description: Chronic inflammation leads to airway hyperresponsiveness and recurrent
    episodes of wheezing, breathlessness, chest tightness, and coughing.
  downstream:
  - target: Bronchoconstriction
    description: Airway hyperresponsiveness provides the substrate for bronchoconstriction
      in response to numerous diverse stimuli.
    evidence:
    - reference: PMID:38395082
      supports: SUPPORT
      snippet: Airway hyperresponsiveness (AHR) is a key clinical feature of asthma.
        The presence of AHR in people with asthma provides the substrate for bronchoconstriction
        in response to numerous diverse stimuli, contributing to airflow limitation
        and symptoms including breathlessness, wheeze, and chest tightness.
      explanation: This review establishes the mechanistic link between airway hyperresponsiveness
        and bronchoconstriction in asthma, showing that AHR enables bronchoconstriction
        when triggered by various stimuli.
  cell_types:
  - preferred_term: Mast Cell
    term:
      id: CL:0000097
      label: mast cell
  - preferred_term: Eosinophil
    term:
      id: CL:0000771
      label: eosinophil
  - preferred_term: T-Lymphocyte
    term:
      id: CL:0000084
      label: T cell
  - preferred_term: Bronchial Epithelial Cell
    term:
      id: CL:0002328
      label: bronchial epithelial cell
  - preferred_term: Basophil
    term:
      id: CL:0000767
      label: basophil
  - preferred_term: Neutrophil
    term:
      id: CL:0000775
      label: neutrophil
  evidence:
  - reference: PMID:18503727
    supports: SUPPORT
    snippet: The pathogenesis of allergic airway inflammation is complex, involving
      multiple cell types such as T helper 2 cells, regulatory T cells, eosinophils,
      dendritic cells, mast cells, and parenchymal cells of the lung.
    explanation: This reference indicates the involvement of multiple cell types,
      including mast cells, eosinophils, and T lymphocytes in allergic airway inflammation,
      which supports the statement.
  - reference: PMID:8324396
    supports: SUPPORT
    snippet: The numbers of eosinophils and neutrophils are increased 4 h after challenge
      with allergen in the broncho-alveolar lavage fluid (BAL) of asthmatics who show
      an LPR.
    explanation: This reference mentions eosinophils and neutrophils as part of the
      chronic inflammatory response in asthma, supporting the statement.
  - reference: PMID:9753516
    supports: SUPPORT
    snippet: Accumulation of basophils and mast cells in airway tissues during allergic
      and allergic-type inflammatory responses, including asthma, is one of the hallmarks
      of these disease processes.
    explanation: This reference highlights the involvement of basophils and mast cells
      in airway inflammation in asthma, supporting the statement.
  - reference: PMID:38395082
    supports: SUPPORT
    snippet: Airway hyperresponsiveness (AHR) is a key clinical feature of asthma.
      The presence of AHR in people with asthma provides the substrate for bronchoconstriction
      in response to numerous diverse stimuli, contributing to airflow limitation
      and symptoms including breathlessness, wheeze, and chest tightness.
    explanation: This reference supports the clinical manifestations of asthma as
      described in the statement.
  - reference: PMID:23234454
    supports: PARTIAL
    snippet: Pulmonary edema and pulmonary vascular congestion have been thought to
      be the primary causes of cardiac asthma but most patients have a poor response
      to diuretics... Evidence suggests that circulating inflammatory factors and
      tissue growth factors also lead to airway obstruction suggesting the possibility
      of developing novel therapies.
    explanation: While this reference focuses on cardiac asthma, it acknowledges the
      involvement of inflammatory factors leading to airway obstruction, which partially
      supports the inflammatory aspect mentioned.
  - reference: PMID:1571812
    supports: SUPPORT
    snippet: Asthmatics can have a blood eosinophilia which in some studies correlates
      with the severity of the disease... The eosinophils that contribute to asthma
      will be those in the lung.
    explanation: Specifically talks about the role of eosinophils in asthma, supporting
      the statement.
  - reference: PMID:28687463
    supports: SUPPORT
    snippet: NAEB shares similar eosinophilic inflammation of airway and response
      to corticosteroids with asthma.
    explanation: This supports the role of eosinophils in airway inflammation in asthma,
      consistent with the statement.
  - reference: PMID:6101920
    supports: NO_EVIDENCE
    snippet: Exercise-induced asthma can appear as one of many forms of airway hyperreactivity
      or as a unique clinical entity.
    explanation: Does not provide specific information about the role of the cell
      types mentioned in the statement.
- name: Bronchoconstriction
  description: During an asthma attack, smooth muscles around the airways tighten
    and narrow the airway.
  cell_types:
  - preferred_term: Smooth Muscle Cells
    term:
      id: CL:0000192
      label: smooth muscle cell
  evidence:
  - reference: PMID:24914235
    supports: SUPPORT
    snippet: The other main cause of airway obstruction is contraction of airway smooth
      muscle.
    explanation: The reference points out that contraction of airway smooth muscle
      is a main cause of airway obstruction, thus supporting the statement.
  - reference: PMID:22011234
    supports: SUPPORT
    snippet: Breathing difficulties are caused by excessive narrowing of the pulmonary
      airways, which is instigated by shortening of the airway smooth muscle (ASM).
    explanation: This reference explains that the narrowing of the airways, caused
      by the contraction of airway smooth muscle, leads to breathing difficulties,
      thus supporting the statement.
  - reference: PMID:27603525
    supports: SUPPORT
    snippet: In acute and chronic allergen driven animal models of asthma, statins
      reduce airway hyper-responsiveness, inflammation and remodeling.
    explanation: The use of statins to reduce airway hyper-responsiveness implies
      the involvement of smooth muscle cells, supporting the statement.
  - reference: PMID:16543052
    supports: SUPPORT
    snippet: ASM plays an important role in regulating bronchomotor tone, in perpetuating
      airway inflammation, and in remodeling of the airways.
    explanation: This reference highlights multiple functions of airway smooth muscle
      in asthma, which supports the statement regarding the role of smooth muscle
      cells in bronchoconstriction.
  - reference: PMID:18669785
    supports: SUPPORT
    snippet: Airway smooth muscle cells are known to be the main effector cells of
      airway narrowing.
    explanation: This reference clearly identifies airway smooth muscle cells as key
      players in the narrowing of airways (bronchoconstriction), thus supporting the
      statement.
- name: Mucus Overproduction
  description: Inflammatory cells infiltrate the airways, increasing mucus production,
    which can block airways and further impair breathing.
  cell_types:
  - preferred_term: Goblet Cell
    term:
      id: CL:0000160
      label: goblet cell
  - preferred_term: Bronchial Epithelial Cell
    term:
      id: CL:0002328
      label: bronchial epithelial cell
  - preferred_term: Mucosal Epithelial Cell
    term:
      id: CL:0002202
      label: epithelial cell of tracheobronchial tree
  evidence:
  - reference: PMID:19689269
    supports: PARTIAL
    snippet: Goblet cells are major mucus-producing cells, and goblet cell hyperplasia
      (GCH) is one feature of airway remodeling, defined as structural changes occurring
      in the airway.
    explanation: The reference confirms Goblet cell involvement in asthma and mucus
      production but does not mention Mucosal Epithelial Cell specifically.
  - reference: PMID:24914235
    supports: PARTIAL
    snippet: Airway epithelial cells, which are the first line of defense against
      inhaled pathogens and particles, initiate airway inflammation and produce mucus,
      an important contributor to airway obstruction.
    explanation: The reference supports that Bronchial Epithelial Cells play a role
      in mucus production but does not discuss Mucosal Epithelial Cells specifically.
  - reference: PMID:37520564
    supports: PARTIAL
    snippet: Basal cells... goblet cell hyperplasia and increased epithelial mesenchymal
      transition, which contribute to impaired mucociliary clearance and airway remodelling.
    explanation: The reference confirms Goblet cell hyperplasia and the contribution
      of epithelial cells in asthma but does not detail Mucosal Epithelial Cells.
  - reference: PMID:23638644
    supports: PARTIAL
    snippet: Goblet cell differentiation and mucus production are subject to extensive
      control. An emerging concept is that not all goblet cells are phenotypically
      identical suggesting that specific molecular pathways orchestrate mucin overproduction.
    explanation: The reference supports Goblet cells&#39; role in mucus production but
      lacks information on Mucosal Epithelial Cells.
  - reference: PMID:16101538
    supports: PARTIAL
    snippet: Bronchial epithelial cells (BEC) are known to play an integral role in
      the airway defense mechanism via mucociliary system as well as mechanical barriers.
    explanation: The reference confirms the involvement of Bronchial Epithelial Cells
      but does not mention Mucosal Epithelial Cells.
- name: Airway Remodeling
  description: Long-standing inflammation can lead to structural changes in the airway,
    permanently affecting lung function.
  cell_types:
  - preferred_term: Fibroblast
    term:
      id: CL:0000057
      label: fibroblast
  - preferred_term: Smooth Muscle Cell
    term:
      id: CL:0000192
      label: smooth muscle cell
  - preferred_term: Bronchial Epithelial Cell
    term:
      id: CL:0002328
      label: bronchial epithelial cell
  evidence:
  - reference: PMID:20500603
    supports: SUPPORT
    snippet: In asthma, it includes alterations of the epithelial cell layer with
      goblet cell hyperplasia, thickening of basement membranes, peri-bronchial and
      peri-bronchoalveolar fibrosis.
    explanation: The reference acknowledges that airway remodeling in asthma involves
      changes to the epithelial cell layer, fibroblasts, and smooth muscle cells.
  - reference: PMID:10907591
    supports: SUPPORT
    snippet: In the long-term, asthma may become moderately to fully irreversible.
      Severe, irreversible airflow obstruction may develop despite apparently appropriate
      therapy.
    explanation: The reference supports the idea that long-standing inflammation can
      result in irreversible structural changes affecting lung function.
  - reference: PMID:15896192
    supports: SUPPORT
    snippet: Structural changes reported in the airways of asthmatics include epithelial
      fragility, goblet cell hyperplasia, enlarged submucosal mucus glands, angiogenesis,
      increased matrix deposition in the airway wall, increased airway smooth muscle
      mass, wall thickening and abnormalities in elastin.
    explanation: The reference details structural changes involving various cell types,
      including epithelial cells, smooth muscle cells, and other airway structures
      resulting from long-term inflammation in asthma.
  - reference: PMID:12405265
    supports: SUPPORT
    snippet: Asthma is a chronic inflammatory disorder of the airways interacting
      with altered structure and function of the formed elements including smooth
      muscle.
    explanation: The reference confirms that chronic inflammation in asthma involves
      structural alterations involving smooth muscle cells and other components, supporting
      airway remodeling.
  - reference: PMID:24914235
    supports: SUPPORT
    snippet: &#39;Two airway cell types are critical for asthma pathogenesis: epithelial
      cells and smooth muscle cells.&#39;
    explanation: The reference highlights the importance of epithelial cells and smooth
      muscle cells in asthma pathogenesis, supporting the role of these cell types
      in airway remodeling.
phenotypes:
- category: Respiratory
  name: Wheezing
  frequency: FREQUENT
  diagnostic: true
  sequelae:
  - target: Respiratory Distress
  - target: Reduced Exercise Tolerance
  evidence:
  - reference: PMID:20545704
    supports: SUPPORT
    snippet: It has been suggested that there are several distinct phenotypes of childhood
      asthma or childhood wheezing. Here, we review the research relating to these
      phenotypes, with a focus on the methods used to define and validate them.
    explanation: The reference supports the existence and classification of asthma
      phenotypes, including wheezing as a common characteristic.
  - reference: PMID:8620967
    supports: SUPPORT
    snippet: Wheezes are usual clinical signs in patients with obstructive airway
      diseases and particularly during acute episodes of asthma.
    explanation: The reference describes wheezing as a common symptom associated with
      asthma, supporting the statement&#39;s claim that wheezing is a common phenotype
      and respiratory diagnostic of asthma.
  - reference: PMID:1788358
    supports: SUPPORT
    snippet: Exercise-induced asthma is a common but frequently undiagnosed problem.
      The patient may not wheeze, but rather have shortness of breath, chest tightening,
      and coughing.
    explanation: This reference mentions exercise-induced asthma and details its symptoms,
      including wheezing, though noting that wheezing may not always be present.
  - reference: PMID:26606077
    supports: SUPPORT
    snippet: The syndrome of asthma contains a number of different phenotypes that
      offer the possibility of personalized medicine based on the respective asthma
      phenotype.
    explanation: Confirms the existence of multiple phenotypes within asthma, including
      wheezing, supporting the statement&#39;s categorization of wheezing as a phenotype
      of asthma.
  - reference: PMID:21722845
    supports: SUPPORT
    snippet: Oral corticosteroids are the cornerstone of management of acute moderate
      or severe asthma whilst preventive inhaled corticosteroids are the mainstay
      of the preventive management of children with asthma. Yet, variation in the
      magnitude of response to corticosteroids has been observed.
    explanation: Supports the statement indirectly by acknowledging variations in
      asthma phenotypes, which includes wheezing as a common symptom.
  - reference: PMID:38716537
    supports: SUPPORT
    snippet: We want to highlight the presentation of a 75-year-old female who was
      initially managed as asthma and subsequently diagnosed with concurrent excessive
      dynamic airway collapse (EDAC).
    explanation: Although the snippet discusses a different case, it implies that
      wheezing is commonly associated with asthma management.
  phenotype_term:
    preferred_term: Wheezing
    term:
      id: HP:0030828
      label: Wheezing
- category: Respiratory
  name: Coughing
  frequency: FREQUENT
  evidence:
  - reference: PMID:36096782
    supports: SUPPORT
    snippet: Asthma is a heterogeneous disease with variable symptoms, which presents
      with cough either as the sole or predominant symptom with or without wheezing.
    explanation: The reference states that cough is a common phenotype in asthma,
      aligning with the statement&#39;s claim that coughing is a common respiratory phenotype
      in asthma.
  - reference: PMID:31662445
    supports: SUPPORT
    snippet: Asthma severity was dependent on variety of symptoms, consisting mostly
      of wheezing, breathlessness, chest tightness, and cough.
    explanation: The reference indicates that coughing is one of the primary symptoms
      associated with asthma, supporting the claim that it is a common respiratory
      phenotype.
  - reference: PMID:36543577
    supports: SUPPORT
    snippet: Chronic cough is associated with poor quality of life and can negatively
      affect quality of life. Diseases causing chronic cough are most commonly asthma,
      eosinophilic bronchitis, gastroesophageal reflux, post-nasal drip syndrome,
      rhinosinusitis, chronic obstructive pulmonary disease, pulmonary fibrosis, and
      bronchiectasis.
    explanation: The reference supports the association of chronic cough with asthma,
      aligning with the statement that coughing is a common phenotype in asthma.
  phenotype_term:
    preferred_term: Coughing
    term:
      id: HP:0012735
      label: Cough
- category: Respiratory
  name: Breathlessness
  frequency: FREQUENT
  evidence:
  - reference: PMID:34610625
    supports: SUPPORT
    snippet: Respiratory diseases were the main underlying condition (40-57%), of
      which asthma was the most common (approx. 25%), and chronic obstructive pulmonary
      disease was particularly strongly associated with breathlessness.
    explanation: The reference indicates that respiratory diseases, including asthma,
      are a common underlying condition for breathlessness. This supports the categorization
      of breathlessness as a common respiratory phenotype of asthma.
- category: Respiratory
  frequency: FREQUENT
  name: Chest Tightness
  review_notes: Added Chest Tightness, which is also a common symptom of asthma.
  evidence:
  - reference: PMID:31662445
    supports: SUPPORT
    snippet: &#39;CONCLUSIONS: Asthma severity was dependent on variety of symptoms, consisting
      mostly of wheezing, breathlessness, chest tightness, and cough.&#39;
    explanation: The literature indicates that chest tightness is among the most common
      symptoms of asthma, supporting the statement that chest tightness is a frequent
      phenotype of respiratory symptoms in asthma patients.
  - reference: PMID:36292755
    supports: SUPPORT
    snippet: Asthma is a chronic disease of the airways characterized by inflammation,
      tightened muscles, and thickened airway walls leading to symptoms such as shortness
      of breath, chest tightness, and cough in patients.
    explanation: This article confirms that chest tightness is a common symptom of
      asthma, supporting the statement.
  - reference: PMID:3595047
    supports: SUPPORT
    snippet: &#39;IMPLICATIONS: exercise-induced asthma should be considered in pediatric
      patients with symptoms of chest pain or dyspnea on exertion.&#39;
    explanation: Exercise-induced asthma includes symptoms like chest pain, which
      is related to chest tightness, supporting the statement.
  - reference: PMID:19463209
    supports: SUPPORT
    snippet: We present the case of a 42-year-old man with a 2-year history of wheezing,
      chest tightness, and upper respiratory symptoms.
    explanation: This case study highlights chest tightness as a symptom, supporting
      the statement as it shows chest tightness is a common feature in asthma triggered
      by recreational activities.
  phenotype_term:
    preferred_term: Chest Tightness
    term:
      id: HP:0031352
      label: Chest tightness
- category: Respiratory
  frequency: FREQUENT
  name: Rapid Breathing
  notes: Increased respiratory rate, especially during an asthma attack
  evidence:
  - reference: PMID:31662445
    supports: SUPPORT
    snippet: Asthma severity was dependent on variety of symptoms, consisting mostly
      of wheezing, breathlessness, chest tightness, and cough.
    explanation: The study mentions breathlessness as a common symptom of asthma,
      which can be associated with rapid breathing, especially during an asthma attack.
  - reference: PMID:27576231
    supports: SUPPORT
    snippet: Asthma is a chronic respiratory disease characterized by chronic airway
      inflammation and variable expiratory airflow limitation. Related clinical features
      include wheezing, dyspnea, chest tightness, and cough that worsens at night
      or in the early morning, and that varies over time and in intensity.
    explanation: Dyspnea, which is mentioned as a related clinical feature of asthma,
      can be associated with rapid breathing.
- category: Respiratory
  frequency: OCCASIONAL
  name: Cyanosis
  notes: Bluish discoloration of skin and mucous membranes due to low oxygen
  evidence:
  - reference: PMID:29601558
    supports: PARTIAL
    snippet: Dyspnea as a subjective feeling of lack of air is the patients with the
      pathology of the respiratory system. Objectivization of this phenomenon is difficult,
      despite the introduction of questionnaires about the degree of dyspnoea. The
      results of these assessments do not always correlate with the results of spirometric
      tests. In patients with asthma, dyspnoea is caused by airway obstruction.
    explanation: While this reference discusses dyspnea in asthma patients, it does
      not explicitly mention cyanosis. However, dyspnea and airway obstruction could
      potentially lead to cyanosis in severe cases.
  phenotype_term:
    preferred_term: Cyanosis
    term:
      id: HP:0000961
      label: Cyanosis
- category: Systemic
  frequency: FREQUENT
  name: Fatigue
  notes: Due to increased work of breathing and sleep disturbance
  evidence:
  - reference: PMID:33783133
    supports: SUPPORT
    snippet: Fatigue as a symptom is common in asthmatic patients and correlates with
      asthma-related quality of life, asthma control, dyspnea, depression and anxiety.
    explanation: The study indicates that fatigue is a common symptom in asthmatic
      patients and is associated with various aspects of asthma, supporting the statement
      that fatigue is frequent in asthma.
  - reference: PMID:33783133
    supports: PARTIAL
    snippet: Future studies are needed to better understand the physical, psychological,
      behavioural and systemic factors that precipitate or perpetuate fatigue in asthma.
    explanation: While the study supports the association of fatigue with asthma,
      it does not explicitly confirm that the increased work of breathing and sleep
      disturbance are the causes of fatigue, hence the partial support.
  phenotype_term:
    preferred_term: Fatigue
    term:
      id: HP:0012378
      label: Fatigue
- category: Activity
  frequency: FREQUENT
  name: Exercise Intolerance
  notes: Worsening of asthma symptoms with physical activity
  evidence:
  - reference: PMID:8088098
    supports: SUPPORT
    snippet: Given sufficient exercise intensity, exercise can trigger acute exacerbations
      in virtually all individuals with asthma.
    explanation: The literature indicates that exercise can trigger asthma symptoms
      in individuals with asthma, supporting the statement that exercise intolerance
      is frequent in asthma patients.
  - reference: PMID:31662445
    supports: SUPPORT
    snippet: Asthma severity was dependent on variety of symptoms, consisting mostly
      of wheezing, breathlessness, chest tightness, and cough.
    explanation: The study highlights that physical activity can exacerbate asthma
      symptoms such as wheezing and breathlessness, indicating exercise intolerance.
  - reference: PMID:34536613
    supports: SUPPORT
    snippet: PA can trigger asthma symptoms.
    explanation: The literature confirms that physical activity can trigger asthma
      symptoms, supporting the statement about exercise intolerance.
  - reference: PMID:20472861
    supports: SUPPORT
    snippet: Exercise can trigger later bronchoconstriction in many patients.
    explanation: The literature indicates that exercise can lead to bronchoconstriction,
      which supports the statement about exercise intolerance in asthma patients.
  - reference: PMID:32280032
    supports: SUPPORT
    snippet: Asthma symptoms can be triggered or magnified during exertion.
    explanation: The literature confirms that exertion can trigger or magnify asthma
      symptoms, supporting the statement about exercise intolerance.
  phenotype_term:
    preferred_term: Exercise Intolerance
    term:
      id: HP:0003546
      label: Exercise intolerance
- category: Sleep
  frequency: FREQUENT
  name: Sleep Disturbance
  notes: Nocturnal asthma can cause nighttime coughing and difficulty sleeping
  evidence:
  - reference: PMID:11990234
    supports: SUPPORT
    snippet: Nocturnal airway narrowing in asthma is often associated with sleep disorders,
      such as episodes of nocturnal and early morning awakening, difficulty in maintaining
      sleep, and day time sleepiness.
    explanation: This reference supports the statement by indicating that nocturnal
      asthma is associated with sleep disturbances, including difficulty in maintaining
      sleep.
  - reference: PMID:31541769
    supports: SUPPORT
    snippet: CoFr during nighttime (asleep) was significantly higher in asthmatic
      patients than in nonasthmatic patients.
    explanation: This reference supports the statement by showing that nighttime cough
      frequency is higher in asthmatic patients, which implies sleep disturbances.
  - reference: PMID:19823913
    supports: SUPPORT
    snippet: Sleep disruption is common in patients with cough and is often the reason
      why they seek medical attention.
    explanation: This reference supports the statement by indicating that sleep disruption
      is common in patients with chronic cough, which includes those with asthma.
  - reference: PMID:28526251
    supports: SUPPORT
    snippet: Results from analyses using structural equation modeling revealed an
      association between worsening asthma-related lung function and poor sleep quality
      in the full sample, as well as better asthma-related lung function at night
      and more optimal sleep efficiency that night.
    explanation: This reference supports the statement by indicating an association
      between worsening asthma-related lung function and poor sleep quality.
  - reference: PMID:26774954
    supports: SUPPORT
    snippet: The prevalence of nocturnal symptoms of asthma is high, and most children
      regularly experience nighttime symptoms.
    explanation: This reference supports the statement by indicating that nocturnal
      symptoms of asthma are prevalent and regularly affect sleep in children.
  phenotype_term:
    preferred_term: Sleep Disturbance
    term:
      id: HP:0002360
      label: Sleep disturbance
- category: Systemic
  frequency: OCCASIONAL
  name: Anxiety
  notes: Asthma attacks can be frightening and cause anxiety about future episodes
  evidence:
  - reference: PMID:10868701
    supports: SUPPORT
    snippet: Both the attacks themselves and the prospect of attacks generate much
      anxiety amongst patients.
    explanation: The reference explains that asthma attacks and the anticipation of
      such attacks can generate significant anxiety among patients, supporting the
      statement that asthma can occasionally cause anxiety.
  - reference: PMID:32720730
    supports: SUPPORT
    snippet: Asthma was significantly associated with anxiety in boys, particularly
      in older boys.
    explanation: This study found a significant association between asthma and anxiety
      in boys, further supporting the statement that asthma can occasionally cause
      anxiety.
  - reference: PMID:35278300
    supports: SUPPORT
    snippet: Another aspect is the relationship of bronchial asthma with the development
      of mood disorders.
    explanation: The reference mentions the relationship between bronchial asthma
      and mood disorders, including anxiety, supporting the statement.
  phenotype_term:
    preferred_term: Anxiety
    term:
      id: HP:0000739
      label: Anxiety
- category: Respiratory
  name: Respiratory Distress
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Respiratory Distress
    term:
      id: HP:0002098
      label: Respiratory distress
- category: Cardiovascular
  name: Reduced Exercise Tolerance
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Reduced Exercise Tolerance
    term:
      id: HP:0003546
      label: Exercise intolerance
biochemical:
- name: Eosinophils
  presence: Elevated
  subtype: Allergic Asthma
  evidence:
  - reference: PMID:27401626
    supports: PARTIAL
    snippet: Asthma is a heterogeneous disease that can be classified into different
      clinical endotypes, depending on the type of airway inflammation, clinical severity,
      and response to treatment. This article focuses on the eosinophilic endotype
      of asthma, which is defined by the central role that eosinophils play in the
      pathophysiology of the condition.
    explanation: The reference supports that eosinophils are elevated in eosinophilic
      asthma, but does not specifically mention the allergic asthma subtype.
  - reference: PMID:30303258
    supports: SUPPORT
    snippet: There was a significantly higher serum IL-33 level in the eosinophilic
      asthma group when compared to the group of non-eosinophilic asthma patients
      (1001.10 +/- 199.11 pg/mL vs 337.49 +/- 72.68 pg/mL, P &lt; 0.01).
    explanation: The reference mentions a higher level of eosinophils in eosinophilic
      asthma, which can be associated with allergic asthma.
  - reference: PMID:31944632
    supports: PARTIAL
    snippet: Elevated FeNO in nonasthmatic adolescents was associated with airway
      hyperresponsiveness, elevated blood eosinophil counts, and lower systemic activation
      of neutrophils.
    explanation: This reference supports elevated eosinophils but focuses on nonasthmatic
      adolescents rather than allergic asthma specifically.
  - reference: PMID:36115752
    supports: PARTIAL
    snippet: Elevated total IgE concentrations and eosinophil counts are classic biological
      markers regularly found in severe asthma.
    explanation: Although the statement is specific to severe asthma, it indicates
      elevated eosinophils which may also be relevant to allergic asthma.
  - reference: PMID:33479910
    supports: SUPPORT
    snippet: Asthmatic airway inflammation is initiated by inflammatory mediators
      released by granulocytic cells. However, the immunoglobulin E (IgE) antibody
      is necessary for the initiation of the allergic cascade, and IgE is produced
      and released exclusively by memory B cells and plasma cells.
    explanation: The reference supports the statement by linking allergic asthma with
      IgE, which is often associated with elevated eosinophils.
  context: allergic asthma
- name: Neutrophils
  presence: Elevated
  subtype: Non-Allergic Asthma
  evidence:
  - reference: PMID:33830849
    supports: SUPPORT
    snippet: Neutrophilic asthma is associated with poorer responses to classic therapies,
      namely (inhaled) corticosteroids.
    explanation: The document discusses neutrophilic asthma, a subtype of asthma characterized
      by elevated neutrophils, indicating that neutrophils are indeed elevated in
      some forms of asthma, including non-allergic ones.
  - reference: PMID:28163052
    supports: SUPPORT
    snippet: RA was associated with increased numbers of neutrophils and proneutrophilic
      biomolecules in the airways.
    explanation: This reference supports the statement by indicating that refractory
      asthma, which often overlaps with non-allergic asthma, is associated with elevated
      neutrophils.
  - reference: PMID:36871881
    supports: SUPPORT
    snippet: Corticosteroid resistance, progressive lung function decline, and frequent
      asthma exacerbations are the hallmarks of neutrophilic asthma (NA).
    explanation: The study highlights neutrophilic asthma, a type often linked with
      non-allergic inflammatory processes, which supports the elevation of neutrophils
      in such asthma subtypes.
  context: non-allergic asthma
- name: IgE Antibodies
  presence: Elevated
  context: allergic reactions
  evidence:
  - reference: PMID:33479910
    supports: SUPPORT
    snippet: However, the immunoglobulin E (IgE) antibody is necessary for the initiation
      of the allergic cascade, and IgE is produced and released exclusively by memory
      B cells and plasma cells. Acute allergen exposure has also been shown to increase
      IgE levels in the airways of patients diagnosed with allergic asthma.
    explanation: The text indicates that IgE antibodies are necessary for the allergic
      cascade in asthma and are elevated after acute allergen exposure.
  - reference: PMID:20406591
    supports: SUPPORT
    snippet: As many as 90-95% of patients with asthma have aeroallergen sensitization
      and the pattern varies with ethnicity, location of residence, and onset of asthma,
      but not age.
    explanation: The reference mentions higher levels of IgE are common in patients
      with asthma and aeroallergen sensitization.
  - reference: PMID:27264001
    supports: SUPPORT
    snippet: However, there are syndromes in which the relationship between exposure
      to the relevant allergen and the &#39;allergic&#39; disease is not clear. In these cases
      the presence of specific IgE antibodies can play an important role in identifying
      the relevant allergen and provide a guide to therapy. Good examples include
      chronic asthma and exposure to perennial indoor allergens and asthma related
      to fungal infection.
    explanation: Elevated IgE antibodies play a role in chronic asthma and identifying
      relevant allergens, supporting the statement.
  - reference: PMID:30342581
    supports: SUPPORT
    snippet: Using IgE as a biomarker for asthma provides a target for management
      and treatment.
    explanation: The reference supports the use of IgE as a biomarker in asthma, indicating
      its elevated presence in the condition.
  - reference: PMID:16462678
    supports: SUPPORT
    snippet: Atopy is defined by abnormal IgE production in response to an allergen
      (an antigen that is then designated an allergen).
    explanation: The reference defines atopy in terms of elevated IgE production in
      response to allergens, which is relevant to allergic asthma.
genetic:
- name: IL4
  association: Associated
  evidence:
  - reference: PMID:23070918
    supports: SUPPORT
    snippet: The results indicated that there were an association between the IL-4
      C-33T (P = 0.006) and C-589T (P = 0.04) ... and susceptibility to asthma.
    explanation: This meta-analysis found a significant association between IL-4 polymorphisms
      (C-33T and C-589T) and asthma susceptibility.
  - reference: PMID:10073323
    supports: SUPPORT
    snippet: Using both the candidate gene and the positional cloning approaches,
      there is evidence that predisposing factors, if not the disease itself, are
      genetically transferred.
    explanation: This reference generally supports the idea of genetic associations
      in asthma, including those likely involving IL-4.
  - reference: PMID:21325943
    supports: PARTIAL
    snippet: Genotype combinations of IL-4 receptor-alpha and CD14 single nucleotide
      polymorphisms (SNPs) were significantly associated with diisocyanate asthma.
    explanation: This study refers to IL-4 receptor-alpha and not IL-4 directly, and
      its context is specific to occupational asthma caused by diisocyanate exposure.
- name: IL13
  association: Associated
  evidence:
  - reference: PMID:23996716
    supports: SUPPORT
    snippet: Interleukin-13 (IL-13) is known to be a key regulator in immunoglobulin
      E (IgE) synthesis, mucus hypersecretion and airway hyperresponsiveness... A
      statistically significant association of the A-1512C polymorphism in IL13 gene
      was observed with atopy.
    explanation: The study provides evidence that the IL13 gene polymorphism A-1512C
      is significantly associated with asthma.
  - reference: PMID:30539779
    supports: PARTIAL
    snippet: An efficient memory Th2 cell response is dependent on IL-13 produced
      by ILC2s, causing allergic lung inflammation and elevated serum levels of immunoglobulin
      E.
    explanation: The study indicates that IL-13 is involved in allergic lung inflammation
      which is relevant to asthma, but it primarily discusses IL-13&#39;s role in mediating
      immune responses rather than directly associating IL-13 genetic polymorphisms
      with asthma.
  - reference: PMID:23380221
    supports: PARTIAL
    snippet: Very recently, a novel population of IL-33-responsive innate immune cells,
      the type 2 innate lymphoid cells, was found to produce hallmark TH2 cytokines,
      such as IL-5 and IL-13.
    explanation: The review highlights the role of IL-13 in the pathway involved in
      asthma pathogenesis but does not directly establish a genetic association between
      IL-13 and asthma.
  - reference: PMID:21681015
    supports: NO_EVIDENCE
    snippet: Genome-wide association studies of asthma.
    explanation: The abstract discusses GWAS studies related to asthma but does not
      specifically mention IL13.
- name: ADAM33
  association: Associated
  evidence:
  - reference: PMID:26666372
    supports: SUPPORT
    snippet: A disintegrin and metalloproteinase 33 (ADAM33) gene has been considered
      as an asthma susceptibility gene due to its possible role in airway remodeling,
      abnormal cell proliferation, and differentiation. Association of this gene with
      asthma has been reported in several genetic studies on various populations.
    explanation: This study and its findings directly support the statement about
      the association between the ADAM33 gene and asthma.
  - reference: PMID:19481925
    supports: SUPPORT
    snippet: &#39;Despite this, the field has identified 43 replicated genes from association
      studies. The most frequently replicated are: TNF alpha, IL4, FCERB, Adam 33,
      and GSTP1.&#39;
    explanation: This study acknowledges the genetic association between ADAM33 and
      asthma among other genes, further supporting the statement.
- name: GSDMB
  association: Associated
  evidence:
  - reference: PMID:33963941
    supports: SUPPORT
    snippet: Our results revealed that polymorphic variants rs7216389, rs2290400 and
      rs2305480 are associated with the development of allergic diseases as well as
      with asthma and asthma combined with allergic rhinitis.
    explanation: This reference specifically mentions GSDMB polymorphisms and their
      association with asthma.
- name: HLA-DQ
  association: Associated
  evidence:
  - reference: PMID:23181788
    supports: SUPPORT
    snippet: Overall, our findings further replicate the HLA-DQ region in the pathogenesis
      of asthma.
    explanation: The study highlights the association of HLA-DQ genes, specifically
      HLA-DQA1, with asthma in adults, corroborating previous findings linking HLA-DQ
      to asthma susceptibility.
- association: Associated
  name: ORMDL3
  review_notes: Added another gene commonly associated with asthma for completeness.
  evidence:
  - reference: PMID:25167772
    supports: SUPPORT
    snippet: The results of this meta-analysis firmly established that genetic variation
      at the rs7216389 locus, which controls the expression of the ORMDL3, may be
      a major, independent predisposing factor for asthma in ethnically diverse populations.
    explanation: The meta-analysis confirms the association between the ORMDL3 gene
      and asthma susceptibility.
  - reference: PMID:18754760
    supports: PARTIAL
    snippet: It is far from being clear which gene caused the association signal,
      as it is derived from a large linkage disequilibrium (LD) block.
    explanation: The study suggests an association signal that includes ORMDL3 but
      indicates uncertainty about the specific gene responsible due to a large LD
      block.
  - reference: PMID:21276132
    supports: SUPPORT
    snippet: The first GWAS for asthma discovered a novel associated locus on chromosome
      17q21 encompassing the genes ORMDL3, GSDMB and ZPBP2.
    explanation: This GWAS identifies ORMDL3 as part of a locus associated with asthma.
environmental:
- name: Allergens
  notes: Triggering factor for allergic asthma
  evidence:
  - reference: PMID:26788835
    supports: PARTIAL
    snippet: Persons with asthma and multiple diagnoses reported odorous/pungent and
      building-related environmental factors to trigger symptoms to a larger extent
      than did the reference group, mainly due to perfume and odors from flowers.
    explanation: This supports the role of environmental factors in triggering symptoms
      in people with asthma but does not specifically address allergens as a triggering
      factor.
  - reference: PMID:29732974
    supports: SUPPORT
    snippet: The link between asthma and food allergy has been well researched over
      the years; although the exact interplay between the two atopic conditions is
      yet to be fully described. Research suggests that children who have both asthma
      and food allergy are at greater risk of more severe asthmatic episodes.
    explanation: This supports the idea that allergens (specifically food allergies)
      can trigger severe asthma attacks.
  - reference: PMID:20406590
    supports: SUPPORT
    snippet: A complex interplay of genetic predisposition and environmental influences
      results in the clinical picture of allergic asthma.
    explanation: This supports the role of environmental influences, which includes
      allergens, in allergic asthma.
  - reference: PMID:29310764
    supports: SUPPORT
    snippet: The implementation of policies to reduce environmental allergic triggers
      can be an important adjunct to optimal patient care for allergic rhinitis and
      allergic asthma.
    explanation: It supports that allergic asthma can be triggered by environmental
      allergens.
  - reference: PMID:29345235
    supports: SUPPORT
    snippet: The rising frequency of obstructive respiratory diseases during recent
      years, in particular allergic asthma, can be partially explained by changes
      in the environment, with the increasing presence in the atmosphere of chemical
      triggers (particulate matter and gaseous components such as nitrogen dioxide
      and ozone) and biologic triggers (aeroallergens).
    explanation: This directly supports the role of environmental allergens as triggers
      for allergic asthma.
  - reference: PMID:23574397
    supports: SUPPORT
    snippet: For patients with asthma, exacerbations and poor control can result from
      exposure to environmental triggers, such as allergens and air particulates.
    explanation: This supports the idea of allergens being environmental triggers
      for asthma.
  - reference: PMID:31187658
    supports: SUPPORT
    snippet: Environmental exposures varied across the year and demonstrated seasonal
      patterns.
    explanation: This supports the role of environmental allergens like mold in triggering
      asthma.
  - reference: PMID:21277508
    supports: SUPPORT
    snippet: Extrinsic factors include environmental exposure to temperature, humidity,
      aeroallergens, irritants, and pollution.
    explanation: This supports the role of environmental allergens in asthma.
  - reference: PMID:37480203
    supports: SUPPORT
    snippet: Pollen is a key source of aeroallergens responsible for allergic rhinitis,
      conjunctivitis, and asthma.
    explanation: This supports the role of environmental allergens like pollen in
      triggering allergic asthma.
  exposure_term:
    preferred_term: Allergen exposure
    term:
      id: ECTO:0000726
      label: exposure to allergen
- name: Air Pollution
  notes: Exacerbates symptoms
  evidence:
  - reference: PMID:10518814
    supports: SUPPORT
    snippet: Air pollution is convincingly associated with many signs of asthma aggravation.
    explanation: The article states that air pollution is associated with various
      signs and symptoms of asthma aggravation, supporting the statement that air
      pollution exacerbates asthma symptoms.
  - reference: PMID:21277508
    supports: SUPPORT
    snippet: Extrinsic factors include environmental exposure to temperature, humidity,
      aeroallergens, irritants, and pollution.
    explanation: The article discusses how environmental factors, including pollution,
      can result in impaired function of the airways of athletes, which supports the
      statement.
  - reference: PMID:31187658
    supports: SUPPORT
    snippet: Increases in mold and PM10 were associated with increases in asthma claims.
    explanation: The study found associations between particulate pollution and increased
      asthma claims, supporting the statement.
  - reference: PMID:31239087
    supports: SUPPORT
    snippet: Days with historically high associations between pollution and asthma
      attacks were identified as supplemental warning days.
    explanation: The framework identifies days with high pollution as high-risk days
      for asthma attacks, supporting the statement.
  - reference: PMID:31765853
    supports: SUPPORT
    snippet: Exacerbations are largely driven by environmental exposures including
      pollutants, stress, and viral and bacterial pathogens.
    explanation: The text supports the notion that pollutants, including air pollution,
      drive exacerbations of asthma symptoms.
  - reference: PMID:35307034
    supports: SUPPORT
    snippet: The risk ratio for asthma patients to be hospitalised on the same day
      of NO2 exposure was 1.101 per 10 µg/m3 NO2 increase.
    explanation: The study observed a significant increase in hospitalization risk
      for asthma patients due to NO2 exposure, supporting the statement.
  exposure_term:
    preferred_term: Air pollution exposure
    term:
      id: ECTO:8000036
      label: exposure to air pollution
- name: Tobacco Smoke
  notes: Major risk factor for symptom severity
  evidence:
  - reference: PMID:25584912
    supports: SUPPORT
    snippet: Exposure to passive smoke as a risk factor for asthma onset in childhood.
    explanation: The study highlights how environmental tobacco smoke (ETS) is a significant
      indoor pollutant and a likely cause for asthma onset and severity in childhood.
  - reference: PMID:29292313
    supports: SUPPORT
    snippet: Exposure to environmental tobacco smoke increases pediatric asthma severity.
    explanation: The study found that higher state tax grades on tobacco were associated
      with reduced asthma severity, indicating the detrimental impact of tobacco smoke
      on asthma severity.
  - reference: PMID:35236762
    supports: NO_EVIDENCE
    snippet: We aimed to study the associations between particulate matter with an
      aerodynamic diameter lower than 2.5 µm (PM2.5), black carbon (BC) and NO2 and
      the asthma symptom score in adults.
    explanation: The study focuses on various air pollutants but does not specifically
      address tobacco smoke as an environmental factor affecting asthma severity.
  - reference: PMID:32493146
    supports: NO_EVIDENCE
    snippet: In this Caribbean population, uncontrolled asthma was independently associated
      with obesity, late-onset disease, and comorbidities of sleep apnea and depression.
    explanation: This study does not discuss tobacco smoke specifically as an environmental
      risk factor for asthma severity.
  - reference: PMID:37973258
    supports: NO_EVIDENCE
    snippet: The objective of this article is to review recent literature on the implications
      of extreme weather events such as thunderstorms, wildfires, tropical cyclones,
      freshwater flooding, and temperature extremes in relationship to asthma symptoms.
    explanation: The study reviews the impact of extreme weather events on asthma
      but does not mention tobacco smoke.
  exposure_term:
    preferred_term: Tobacco smoke exposure
    term:
      id: ECTO:6000029
      label: exposure to tobacco smoking
- name: Occupational Exposures
  notes: Exposure to dust, chemicals, or gases in the workplace can trigger asthma
    symptoms.
  evidence:
  - reference: PMID:15579371
    supports: SUPPORT
    snippet: The prevalence of occupational asthma is rising, possibly due to the
      introduction of different chemicals and substances in the workplace. Etiologic
      agents include organic and inorganic compounds that are encountered in a variety
      of industries.
    explanation: This reference explicitly states that occupational exposures to chemicals
      and substances in the workplace can trigger asthma.
  - reference: PMID:33104273
    supports: SUPPORT
    snippet: Dentists are exposed to a variety of airborne chemicals that can act
      as irritants and sensitizers and may give rise to work-related respiratory symptoms.
    explanation: This supports the statement by indicating that occupational exposure
      to airborne chemicals can lead to respiratory symptoms including asthma.
  - reference: PMID:37971937
    supports: SUPPORT
    snippet: Multiple respiratory hazards have been identified in the cannabis cultivation
      and production industry, in which occupational asthma and work-related exacerbation
      of preexisting asthma have been reported.
    explanation: This reference highlights occupational asthma caused by exposure
      to respiratory hazards in the cannabis industry.
  - reference: PMID:19463209
    supports: SUPPORT
    snippet: Common asthma triggers during recreational activities include allergen
      exposure, concomitant viral infection, and exercise.
    explanation: Although this reference discusses recreational triggers, the exposure
      to allergens also supports the idea that similar environmental triggers in occupational
      settings can lead to asthma.
  - reference: PMID:36938642
    supports: SUPPORT
    snippet: Environmental and occupational exposures contribute to its causation.
      WTC-related or aggravated asthma is considered a World Trace Center (WTC) Health
      Program certifiable disease.
    explanation: This supports the statement by acknowledging that occupational exposures
      can contribute to asthma.
  - reference: PMID:29427981
    supports: SUPPORT
    snippet: Low-molecular-weight chemical sensitizers, causes of occupational asthma,
      also cause asthma in a manner analogous to allergen.
    explanation: This reference supports that occupational exposures to chemical sensitizers
      can trigger asthma.
  exposure_term:
    preferred_term: Occupational chemical exposure
    term:
      id: ECTO:0000231
      label: exposure to chemical
treatments:
- name: Inhaled Corticosteroid
  description: Reduce inflammation and prevent flare-ups.
  evidence:
  - reference: PMID:22559870
    supports: SUPPORT
    snippet: Current guidelines recommend long-term treatment with inhaled corticosteroids
      (ICS) because of their superior effectiveness in managing the chronic airway
      inflammation that characterizes persistent asthma.
    explanation: This literature supports the statement that inhaled corticosteroids
      reduce inflammation in asthma.
  - reference: PMID:9817746
    supports: SUPPORT
    snippet: Glucocorticoids are highly effective in the control of asthma and suppression
      of airway inflammation.
    explanation: This reference supports the role of glucocorticoids, which includes
      inhaled corticosteroids, in reducing airway inflammation in asthma.
  - reference: PMID:32868307
    supports: SUPPORT
    snippet: The 2019 Global Initiative for Asthma (GINA) guidelines recommend that
      all asthma patients be treated with inhaled corticosteroids taken daily or as
      needed; this improves symptoms and outcomes, even in those with mild disease.
    explanation: This guideline indicates that inhaled corticosteroids are recommended
      for improving asthma outcomes, supporting their role in preventing flare-ups.
  - reference: PMID:37182593
    supports: SUPPORT
    snippet: Early treatment with inhaled corticosteroids not only diminishes lung
      inflammation and airway hyper-responsiveness, but also has a protective effect
      against the reduction of breathing pattern complexity due to asthma.
    explanation: The findings indicate that early treatment with inhaled corticosteroids
      reduces lung inflammation and helps prevent further complications, such as reduced
      breathing pattern complexity, supporting their role in preventive care.
  treatment_term:
    preferred_term: respiratory tract agent therapy
    term:
      id: MAXO:0000312
      label: respiratory tract agent therapy
- name: Long-acting Beta Agonist
  description: Relax the muscles around the airways.
  evidence:
  - reference: PMID:34753370
    supports: SUPPORT
    snippet: Patients experience significant clinical benefits from therapy with long-acting
      β2-agonists (LABAs) with efficacy to bronchodilate, and prolonged lung function
      betterment.
    explanation: The literature supports that LABAs help in relaxing the muscles around
      the airways, thereby improving lung function and providing symptomatic relief
      in asthma management.
  - reference: PMID:37489386
    supports: SUPPORT
    snippet: Long-acting muscarinic antagonists (LAMAs) are a class of inhalers that
      has recently been included as add-on therapy in the GINA guidelines, either
      in a single inhaler device with inhaled corticosteroids plus long-acting beta2-agonists
      (ICS + LABA).
    explanation: Although primarily about LAMAs, the literature acknowledges that
      LABAs are part of the recommended treatment regimen for asthma, which implies
      their role in relaxing airway muscles.
  - reference: PMID:32306788
    supports: SUPPORT
    snippet: Contemporary mainstay therapies (inhaled corticosteroids and bronchodilators),
      prescribed empirically, control symptoms resulting from airways obstruction
      tolerably well in many patients...
    explanation: The literature indicates that LABAs, as bronchodilators, help control
      symptoms related to airway obstruction by relaxing the airway muscles.
  treatment_term:
    preferred_term: respiratory tract agent therapy
    term:
      id: MAXO:0000312
      label: respiratory tract agent therapy
- name: Leukotriene Modifier
  description: Reduce inflammation, decrease mucus secretion, and prevent airway constriction.
  evidence:
  - reference: PMID:14720013
    supports: SUPPORT
    snippet: Leukotriene modifiers increase the therapeutic options for patients with
      asthma and, based on recent data, it is expected that future guidelines will
      describe expanded uses for these agents in clinical circumstances where these
      drugs are effective.
  - reference: PMID:11085767
    supports: SUPPORT
    snippet: Their unique mechanism of action results in a combination of both bronchodilator
      and anti-inflammatory effects.
  - reference: PMID:19180262
    supports: SUPPORT
    snippet: Cysteinyl leukotrienes, which are derivatives of the 5-lipoxygenase pathway
      of arachidonic acid metabolism, are important mediators of airway allergic inflammation
      and have a role in the pathogenetic mechanism of EIB. Montelukast sodium (Singulair,
      Merck &amp; Co.) is a selective and orally active leukotriene receptor antagonist
      with demonstrated activity for treating asthma and allergic rhinitis.
  treatment_term:
    preferred_term: respiratory tract agent therapy
    term:
      id: MAXO:0000312
      label: respiratory tract agent therapy
- name: Anti-IgE Therapy
  description: Used to treat severe allergic asthma by blocking IgE, a key chemical
    in the allergic response.
  evidence:
  - reference: PMID:29427989
    supports: SUPPORT
    snippet: Severe allergic asthma and severe eosinophilic asthma are two defined
      phenotypes for which there are efficacious targeted biologic therapies currently
      available, namely anti-immunoglobulin E (IgE) and anti-interleukin (IL)-5 antibodies,
      respectively.
    explanation: This reference confirms that anti-IgE therapy is used to treat severe
      allergic asthma.
  - reference: PMID:20799475
    supports: SUPPORT
    snippet: Among these is anti-IgE, which directly targets IgE serum antibodies,
      thus inhibiting the central mechanism of immediate type hypersensitivity reactions.
      Application of anti-IgE antibodies effectively reduces IgE serum levels regardless
      of allergen specificity.
    explanation: This reference supports that anti-IgE therapy is used in allergic
      asthma by targeting and reducing IgE.
  - reference: PMID:28635659
    supports: SUPPORT
    snippet: Blocking IgE with monoclonal antibodies such as omalizumab have demonstrated
      their efficacy, effectiveness, and safety in treating allergic asthma.
    explanation: This reference confirms that anti-IgE therapy, specifically using
      omalizumab, is effective in treating allergic asthma.
  - reference: PMID:21114196
    supports: SUPPORT
    snippet: Omalizumab improves quality of life of patients with severe persistent
      allergic asthma that is inadequately controlled by currently available asthma
      medications. This therapy is well tolerated and significantly improves symptoms,
      disease control, reducing asthma exacerbations and the need to use high dosage
      of inhaled corticosteroids.
    explanation: This reference further supports the efficacy of anti-IgE therapy
      (omalizumab) in treating severe allergic asthma by improving symptoms and reducing
      exacerbations.
  treatment_term:
    preferred_term: respiratory tract agent therapy
    term:
      id: MAXO:0000312
      label: respiratory tract agent therapy
- description: Provides rapid relief from acute asthma symptoms.
  name: Short-acting Beta Agonist
  review_notes: Added Short-acting Beta Agonist for completeness in treatment options.
  evidence:
  - reference: PMID:34369231
    supports: SUPPORT
    snippet: Albuterol is the most common fast acting medication for asthma, and it
      exists in multiple forms, including metered-dose inhaler and nebulized therapy.
    explanation: Albuterol, a commonly used short-acting beta agonist, is indicated
      as a fast-acting medication for the relief of asthma symptoms.
  - reference: PMID:30297688
    supports: SUPPORT
    snippet: Initial therapy in the stepwise approach for asthma management is short-acting
      β₂-agonist (SABA) therapy as needed for symptom control.
    explanation: Short-acting beta agonists are recommended as initial therapy for
      the control of asthma symptoms, indicating their rapid relief properties.
  - reference: PMID:27588581
    supports: SUPPORT
    snippet: Results demonstrate the efficacy of short-acting beta-agonist (SABA)
      delivered by metered-dose inhaler as first-line therapy for younger and older
      children.
    explanation: The efficacy of SABAs as a first-line therapy in emergency asthma
      management highlights their role in providing rapid relief from acute asthma
      symptoms.
  - reference: PMID:32482150
    supports: SUPPORT
    snippet: A majority of patients uses daily quick-relief medication, with the belief
      that it is the most important treatment because of its rapid onset of action.
    explanation: The use of quick-relief medication, such as SABAs, by a majority
      of patients for asthma management is based on their rapid onset of action.
  - reference: PMID:11253864
    supports: SUPPORT
    snippet: &#39;Clinical studies comparing the effectiveness of (R)-albuterol (levalbuterol)
      with racemic albuterol established a strong rationale for using single-isomer
      beta-agonists in place of the racemic mixture: reduced dosages provide equivalent
      bronchodilatory effects with fewer beta-mediated side effects.&#39;
    explanation: Levalbuterol, a single-isomer beta-agonist, is shown to provide effective
      rapid bronchodilation for asthma management.
  treatment_term:
    preferred_term: respiratory tract agent therapy
    term:
      id: MAXO:0000312
      label: respiratory tract agent therapy
disease_term:
  preferred_term: asthma
  term:
    id: MONDO:0004979
    label: asthma
datasets:
# Human bronchial epithelial expression - Type 2 inflammation
- accession: geo:GSE67472
  title: Airway epithelial gene expression in asthma versus healthy controls
  description: &gt;-
    Bronchial epithelial brushings from mild-to-moderate asthmatics (not on
    inhaled steroids) and healthy controls, stratified by Type 2 inflammation
    markers (POSTN, SERPINB2, CLCA1).
  organism:
    preferred_term: human
    term:
      id: NCBITaxon:9606
      label: Homo sapiens
  data_type: MICROARRAY
  sample_types:
    - preferred_term: bronchial epithelial cells
      tissue_term:
        preferred_term: bronchus
        term:
          id: UBERON:0002185
          label: bronchus
      cell_type_term:
        preferred_term: bronchial epithelial cell
        term:
          id: CL:0002328
          label: bronchial epithelial cell
  sample_count: 105
  conditions:
    - mild-to-moderate asthma (n=62)
    - healthy controls (n=43)
  platform: Affymetrix Human Genome U133 Plus 2.0
  publication: PMID:25611785
  notes: &gt;-
    Identifies Type 2 inflammation gene signature. Useful for studying
    eosinophilic asthma endotypes.

# Severity-stratified cohort
- accession: geo:GSE63142
  title: Asthma II
  description: &gt;-
    Bronchial epithelial cells from normal controls, mild-moderate, and
    severe asthmatic patients to identify severity-associated gene expression.
  organism:
    preferred_term: human
    term:
      id: NCBITaxon:9606
      label: Homo sapiens
  data_type: MICROARRAY
  sample_types:
    - preferred_term: bronchial epithelial cells
      cell_type_term:
        preferred_term: bronchial epithelial cell
        term:
          id: CL:0002328
          label: bronchial epithelial cell
  sample_count: 155
  conditions:
    - severe asthma (n=56)
    - mild-moderate asthma (n=72)
    - healthy controls (n=27)
  platform: Agilent Whole Human Genome Microarray 4x44K

# Large nasal epithelium cohort
- accession: geo:GSE152004
  title: Transcriptomic profiles of the nasal epithelium from the Genes-environments &amp; Admixture in Latino Americans (GALA) II study
  description: &gt;-
    Large cohort study of nasal epithelial cells comparing asthmatic
    and control subjects.
  organism:
    preferred_term: human
    term:
      id: NCBITaxon:9606
      label: Homo sapiens
  data_type: MICROARRAY
  sample_types:
    - preferred_term: nasal epithelial cells
      tissue_term:
        preferred_term: nasal cavity mucosa
        term:
          id: UBERON:0001826
          label: nasal cavity mucosa
  sample_count: 393
  conditions:
    - asthma (n=257)
    - controls (n=136)

# Single-cell dataset
- accession: geo:GSE164015
  title: Epithelial miR-141 regulates IL-13-induced airway mucus production [single-cell RNA-seq]
  description: &gt;-
    Single-cell RNA sequencing of airway epithelial cells from asthmatic
    patients revealing cell-type specific transcriptional changes.
  organism:
    preferred_term: human
    term:
      id: NCBITaxon:9606
      label: Homo sapiens
  data_type: SINGLE_CELL_RNA_SEQ
  sample_types:
    - preferred_term: airway epithelial cells
      cell_type_term:
        preferred_term: epithelial cell of tracheobronchial tree
        term:
          id: CL:0002202
          label: epithelial cell of tracheobronchial tree
  conditions:
    - asthmatic patients
  notes: Reveals cell-type specific heterogeneity in asthmatic airways

# Cigarette/e-cigarette exposure study
- accession: geo:GSE82137
  title: Molecular impact of electronic cigarette aerosol exposure in human bronchial epithelium
  description: &gt;-
    Primary human bronchial epithelial cells grown at air-liquid interface,
    exposed to whole tobacco cigarette smoke and electronic cigarette aerosol.
  organism:
    preferred_term: human
    term:
      id: NCBITaxon:9606
      label: Homo sapiens
  data_type: MICROARRAY
  sample_types:
    - preferred_term: primary bronchial epithelial cells (ALI culture)
      cell_type_term:
        preferred_term: bronchial epithelial cell
        term:
          id: CL:0002328
          label: bronchial epithelial cell
  conditions:
    - tobacco cigarette smoke (48 puffs)
    - e-cigarette aerosol (menthol flavor, +/- nicotine)
    - e-cigarette aerosol (tobacco flavor, +/- nicotine)
    - control
  exposures:
    - preferred_term: tobacco smoke exposure
      term:
        id: ECTO:6000029
        label: exposure to tobacco smoking
  notes: Compares traditional vs electronic cigarette effects on airway epithelium

# Mouse OVA model
- accession: geo:GSE11911
  title: Gene expression profiling of experimental asthma reveals a possible role of paraoxonase-1 in asthma
  description: &gt;-
    Gene expression from lung tissue of ovalbumin-sensitized and challenged
    BALB/c mice modeling allergic airway inflammation.
  organism:
    preferred_term: mouse
    term:
      id: NCBITaxon:10090
      label: Mus musculus
  data_type: MICROARRAY
  sample_types:
    - preferred_term: whole lung tissue
      tissue_term:
        preferred_term: lung
        term:
          id: UBERON:0002048
          label: lung
  conditions:
    - OVA-sensitized and challenged
    - control
  exposures:
    - preferred_term: ovalbumin allergen challenge
      term:
        id: ECTO:0000726
        label: exposure to allergen
  notes: Classic murine allergic airway inflammation model
</pre>
            </div>
        </div>

        <footer class="page-footer">
            <p>
                Generated from <a href="https://github.com/monarch-initiative/dismech" target="_blank">dismech</a>
                knowledge base
            </p>
            <p style="margin-top: 8px;">
                <a href="https://github.com/monarch-initiative/dismech/blob/main/kb/disorders/Asthma.yaml" target="_blank">View source on GitHub</a>
            </p>
        </footer>
    </div>

    <script>
        function toggleYaml() {
            const content = document.getElementById('yamlContent');
            const toggleText = document.getElementById('yamlToggleText');
            content.classList.toggle('show');
            toggleText.textContent = content.classList.contains('show') ? 'click to hide' : 'click to show';
        }
    </script>
</body>
</html>